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Abstract 
Optimization and characterization of microwave-assisted extraction (MAE) and ultrasonic-
solvent extraction (USE) of drugs from bone was developed and compared to standard passive 
extraction. Extraction solvent, sample mass, extraction time, solvent volume, microwave power 
and presence of dissolved gasses in bath-water and extraction solvent were investigated. Solvent 
extracts were assayed by GC-MS (EI-SIM) or ULPC-DAD.  
Higher yields were obtained with methanol while sample mass had no effect on analyte recovery. 
Maximum yield was achieved within 30, 15 and 45 min of passive extraction, MAE and USE, 
respectively. Solvent volume did not influence analyte recovery for MAE, but larger and smaller 
solvent volumes obtained higher yields for passive extraction and USE, respectively. Higher 
microwave power resulted in greater recovery and degassed bath-water and extracting solvent 
resulted in significantly higher recovery. Higher recovery was achieved with passive extraction, 
MAE and USE are more time efficient, and more cost efficient and environmentally friendly, 
respectively. 
 
Keywords: Forensic toxicology, bone, microwave-assisted-extraction, ultrasonic-solvent 
extraction, drug, GC-MS, UPLC-DAD. 
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Chapter 1 
1 Introduction 
1.1 General Introduction to Forensic Toxicology 
Forensic toxicology is a branch of forensic science which applies principles of different 
disciplines, such as pharmacology, analytical chemistry and clinical chemistry, to assist legal and 
medical investigations of drug use, poisoning and death. Toxicological analysis of samples may 
determine the role of drugs in medico-legal death investigations, in cases of unnatural and 
suspicious deaths.  
 
 
1.2  Post-Mortem Toxicology Samples 
Conventional specimens collected at autopsy for toxicological analysis include bodily fluids such 
as blood (central [ex: heart] and peripheral [ex: femoral]), urine, vitreous humor, stomach 
contents, bile, and organs such as liver, kidneys, spleen, lungs and brain [1,2]. In situations 
involving animal scavenging, advanced decomposition or skeletonization, conventional tissues 
may be unavailable. Hair, nails, teeth and bone may be the only biological samples remaining 
that can potentially be used for toxicological analysis [1,2,3].  
After collection of specimens, samples must undergo a series of steps prior to analysis, where 
sample preparation is often the longest and most important step of a drug testing procedure. The 
goals of sample preparation are to concentrate the targeted analytes, clean up the sample by 
2	  
	  
reducing interference from endogenous compounds in the matrix and/or separate the analytes 
from the biological matrix and transfer them to a solvent amenable for the analysis. 
Some of the most commonly used procedures in sample preparation include protein and lipid 
precipitation, solid-phase extraction (SPE) and liquid-liquid extraction (LLE). Each technique 
takes advantage of the physiochemical properties of the analyte(s), such as lipophilicity and pKa, 
to achieve solubility in different solvents in order to remove contaminating compounds and 
separate the targeted analytes.  
Screening is often achieved by a combination of spectrometry, simple colour test, 
chromatography or immunoassay. Spectrometry can include spectrophotometry; chromatography 
uses the substance volatility and solubility for the partitioning between the mobile and stationary 
phases of gas and liquid chromatography, respectively. Immunoassay involves the competition 
between labeled drug and the drug or drug-class in the sample for the sites on selective binding 
antibodies [4]. Once the screening technique indicates the presence of potential analytes, 
confirmation must be established. Two of the most common confirmation techniques are GC-MS 
and LC/MS/MS. 
 
 
1.3 Bone Anatomy 
The human skeleton is a metabolically active organ that is composed of 206 bones and is a 
highly specialized form of connective tissue whose main goal is maintaining internal support and 
protecting organs. As a secondary function, bone is also a line of defence against acidosis [2,5]. 
Combined with bone marrow, skeletal tissue makes up approximately 14 % of the average 
3	  
	  
human body mass; a potentially large surface area for adsorption of toxins, metals and drugs 
[2,5,6]. The most abundant cell type in bone are osteocytes: these are surrounded by a 
mineralized extracellular matrix, composed mainly of calcium phosphate (Ca3(PO4)2) combined 
with calcium hydroxide (Ca(OH)2) to form crystals of hydroxyapatite (Ca10(PO4)6(OH)2). On the 
other hand, osteoblasts, osteoclasts and bone lining cells are found on the surface of the bone 
[1,7]. Osteoblasts produce the bone matrix, rendering the tissue strong and rigid, with some 
degree of elasticity. Once surrounded by impermeable bone matrix, osteoblasts mature into 
osteocytes and become responsible for the maintenance of bone tissue and calcium homeostasis, 
through synthesis and resorption of the matrix [6]. Osteoscytes are located in small spaces called 
lacunae and communicate with adjacent osteocytes and blood supply, located at the interior and 
exterior bone surfaces, by canaliculi. This allows diffusion of oxygen, nutrients and waste, and 
deposition of drugs and metabolites into the bone matrix [8].  
Bones are found in 4 different shapes in the human body: long, short, flat and irregular, and 2 
different forms: cortical, also known as compact or dense bone, and cancellous, also called 
trabecular or spongy bone [1,6]. The difference between the 2 forms is both structural and 
functional. Compact bone has very little porosity (5-30 %), accounts for approximately 80 % of 
the total bone mass and has protective and mechanical functions. Compact bone is formed of 
substructures called osteons, also known as Haversian systems, which are organized in 
concentric rings of calcified extracellular matrix called lamellae. Each lamella surrounds a 
Haversian canal, where nerves and blood vessels run longitudinally through the bone (figure 1). 
These nerves and blood vessels branch off the Haversian canal into smaller channels, called 
canaliculi, that penetrate the compact bone in every direction and interconnect lacunae, small 
spaces where osteocytes reside [1,6,9].  
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Figure 1: Sketch of typical long bone illustrating important features of cortical and 
cancellous bone (After Martin, 2007 [9]) 
 
Cancellous bone is formed of a network of trabeculae, which consists of lamellae arranged in an 
irregular pattern, rather than in osteons. This physical attribute makes the bone lighter and more 
porous (30-90 %) and creates a greater surface area for the exchange of waste and nutrients 
between osteocytes and blood vessels. Unlike compact bone, where extracellular fluid fills the 
space in the lacunae and canaliculi, bone marrow fills the space in between the bony rods, 
serving a metabolic function [1,6,8].  
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Bone marrow is also found in the medullary cavity and includes red and yellow marrow. Red 
bone marrow consist of connective tissue rich in vascular supply and contains lots of 
hematopoietic (blood stem cells) cells and white blood cells, in particular macrophages. 
Although yellow bone marrow consists of connective tissue and blood vessels as well, it also 
contains inert adipose cells (fat) [2]. Due to its high vascularity and lipid matrix, bone marrow 
can serve as a drug repository. Winek [10] has demonstrated a correlation between drug levels in 
plasma and bone marrow. For example, an increase of desipramine (DMI) levels in bone marrow 
was observed as the plasma drug levels also increased, showing that bone marrow could be used 
as an alternative tissue for toxicological analysis when blood is unavailable [10]. 
 
 
1.4 Drugs in Bone 
Deposition of drugs in bone is not yet fully understood. Factors such as exact drug location and 
drug time course in bone are still poorly characterized. One can hypothesize that drugs enter 
bone through the circulation system, along with the nutrients and oxygen, transferring from the 
blood vessels into the canaliculi to reach the osteocytes. After death, bone would act as a weakly 
porous box trapping them inside. The drugs can also accumulate in the bone marrow due to its 
high vascularity and fatty matrix. Postmortem, bone marrow would eventually dehydrate during 
skeletonization, where the drugs would reside encased in different parts of bones. Finally, during 
decomposition and liquefaction of organs, drugs and metabolites primarily contained in soft 
organs would eventually be liberated and deposited onto the surface of the bones. Results of 
different studies looking at the distribution of drugs within a bone and between different bones 
showed varying levels of drug recovery [11,12,13,14]. 
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Multiple factors can influence drug and metabolite distribution in bone and bone marrow, such 
as the time since last exposure, frequency of drug intake (acute versus chronic), bone type, and 
drugs’ and metabolites’ physiochemical characteristics. Some compounds may not accumulate or 
may not be transferred from blood to bone as easily as others due to a short half-life, polarity 
(especially metabolites) and protein-binding [1]. 
Results from McGrath’s project on the detection of drugs of forensic importance in post-mortem 
bone demonstrated that in general, drugs were more likely to be detected in blood than bone and 
that a high blood concentration did not always result in high concentration in bone, but that 
certain drugs (ex: nortramadol, cocaethylene and quinine) were detected in higher level in bone. 
Therefore no relationship between drug concentration in blood and the probability of detecting 
the compounds in skeletal tissue could be established [1]. Drug deposition in skeletal tissue can 
therefore be drug dependent and should be investigated for each drug and its metabolites.  
 
 
1.5 Techniques for Drug Isolation from Bone 
Sample preparation is usually the most important and also the most time consuming step of an 
analysis. It includes many different techniques to extract, dissolve, dilute, concentrate, and clean 
up samples in order to increase the sensitivity and selectivity of the analysis.  
The distribution and accumulation of drugs and their metabolites in bone has yet to be 
completely understood. For this reason, their recovery and measurement in bone is challenging 
and poorly characterized. Furthermore, extraction of drugs from solid matrices such as skeletal 
tissue, as opposed to bodily fluids, is more complex due to the heterogeneous solid matrix. As a 
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result, extra steps are required in order to homogenize and then isolate the analytes from the solid 
matrix prior to an extraction step. Additionally, matrix effects are commonly observed with this 
tissue type due to its large level of background components.  
Different isolation techniques to recover drugs and metabolites from skeletal tissue have been 
attempted. The first method found in literature was by Terazana and Takatori in 1982, where the 
cortical part of a humerus from a buried body, with an estimated post-mortem interval of 2-5 
years, was used to perform acid digestion [15]. Acid digestion was accomplished with 1 g of 
ground bone added to 16 mL of 3 N HNO3 for 18 h at room temperature to demineralise the 
bone. This technique has since been used in multiple reports with slight changes to the 
procedure. Raikos et al. detected opiates from a femur of a fatal poising case and compared 
levels with a piece that was later buried for a year. In this case, demineralization was carried out 
similarly but for a total of 24 h [16]. Guillot et al. also used acid incubation to perform bone 
hydrolysis to recover the analytes; in this case 0.1 M HCl was used on 50 mg of bone at 55 °C 
for 12 h [3]. 
Soxhlet extraction has also been used for the extraction of drugs and metabolites from 
skeletonised tissue. In 1985, Banko reported the extraction of amobarbital and glutethimide from 
multiple organs, including bone, from 10 bodies where poisoning was evident at autopsy. Reflux 
was performed for 1 h with 96 % ethanol at pH 3 [17]. Wohlenberg reported using soxhlet 
extraction for nortriptyline extraction from cancellous vertebra bones of a suicide victim; bones 
were cut into 1-2 cm pieces and extracted with 350 mL of methanol overnight (15 h) [18].  
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1.6 Standard Passive Extraction 
Standard passive extraction has been the most widely applied method for the isolation of drugs 
and metabolites from skeletal tissue in the past decade.  Many report the use of this technique to 
extract a wide variety of drugs [1,2,11,12,13,19,20,21,22]. McIntyre et al. were amongst the first 
to document the recovery of drugs from human mid-femoral bone from case work, which 
included therapeutic drug ingestions and presumptive drug overdose [2]. A total of 12 drugs were 
detected, including antidepressants, antipsychotics and benzodiazepine tranquilizers. Drugs and 
primary metabolites were extracted by soaking 10 g of sectioned bone rings in 25 mL of 
methanol at 50 °C for a period of 18 h [2]. Horak [19,20] and McGrath [21] have followed and 
reported similar techniques, where 1-2 g of bone and bone slivers were incubated in 2-4 mL of 
methanol or water at room temperature for 16-24 h [1,19,20,21]. Since then, Watterson et al. 
[11,12,13,14,22,47,93,96] have reported the optimization of passive solvent extraction technique 
to allow the recovery of multiple drugs and metabolites possessing different chemical properties. 
As little as 0.2-0.3 g of ground bone with 2 mL of methanol can be sufficient to detect drugs in 
skeletal tissues [11,12,13,22].  In general, extraction was performed at 50 °C for a total of 12-72 
h. It is presumed that ground bone yields higher analyte recovery due to the higher surface area 
of the solid matrix exposed to the extraction solvent.  
Isolation techniques used for skeletal tissue have been adapted from environmental toxicology 
for the extraction of pesticides from sediments and soils and detection of lead, mercury and 
arsenic in bone [17]. Over time, these methods have also been modified to accommodate other 
matrices such as hair and teeth [18,23,24]. Acid digestion, Soxhlet extraction and standard 
passive extraction all have long incubation periods (12-72 h), limiting the analytical throughput.  
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1.7 Microwave-Assisted Extraction (MAE) 
1.7.1 History and Applications 
During World War II, radars were developed, which initiated microwave technology growth 
[25]. Originally, microwaves were applied to the treatment of coal in order to remove organic 
sulfur, as well as frozen food tempering and pasta drying. In the mid- 1970s, microwave ovens 
started to be mass produced due to the improvements to the magnetron, making this instrument 
more affordable to the general population [26].  
Once microwave ovens were commercialized, they were first used domestically for cooking and 
scientifically for drying samples [27]. Hesek and Wilson were the first to use microwaves for 
analytical purposes. Before the appearance of microwave ovens, samples such as wet cakes were 
dried on a hot plate or in ovens for 3-4 h. Currently, with the use of microwaves, sample drying 
can be accomplished within 15 min of irradiation. Hesek and Wilson were the first to determine 
that the time required to dry a sample was dependent on the size of the sample and the number of 
samples irradiated simultaneously [27].  
Abu-Samra et al. [28] were the first to use microwave technology for digestion in order to 
determine trace metals from biological samples, as an alternative technique for wet ashing (wet 
digestion) [29]. Today, this technique has been expanded to environmental, biological, 
geological and metallic matrices, including fly ash and coal [30].  
However, it was only in 1986 that the first publication appeared; this report by Gedye et al., 
documented the use of microwave irradiation to carry out organic chemistry reactions, such as 
catalytic hydrogenation of alkenes [31]. This report led to further development in microwave 
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technology, which led to a large publication increase in the mid 1990s [26]. Since then, 
microwave technology has been used for sample drying, digestion, moisture measurement, 
sample clean-up, analyte desorption-adsorption, chromogenic reactions, speciation, nebulization 
of sample solution, hydrolysis, and extraction [30,32,33].  
 
1.7.2 Microwave-Assisted Extraction    
The first publication documenting the use of microwave irradiation for extraction purposes was 
in 1986 by Geyde et al. [31]. This group utilized microwaves for the extraction of lipids and 
pesticides from soils, foods and seeds [30,31,34]. The extraction of organic contaminants with a 
laboratory-grade microwave oven was first introduced by Lopez-Avila et al. in 1994 [34]. Since 
then, microwave-assisted extraction (MAE) has been used for the extraction of pesticides and 
herbicides (including organochlorine pesticides [OCPs], polychlorinated biphenyls [PCBs]), 
polycyclic aromatic hydrocarbons (PAHs), neutral and basic pollutants, and phenols from 
sediments, soil and atmospheric particles [30,35,36]. Microwave irradiation has also been 
applied to extract vitamins, essential oils, medicinal and pharmaceutical products from foods, 
aromatic herbs and plant materials [34,37,38,39]. 
 
1.7.3 Theory behind Microwave Ovens 
Microwaves are non-ionizing electromagnetic waves, between the radio and infrared waves, with 
a frequency range from 0.3 to 300 GHz [26,37]. Commercial microwave ovens normally operate 
at a frequency of 2450 MHz (wavelength of 12.2 cm) to avoid interferences and produces 0.23 
cal/mol (0.963 J/mol) of energy (quantum energy of approximately 0.0016 eV, below any 
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chemical bond energy) [26,40,41]. At this frequency the electric field alternates 4.9 x 10⁹ sˉ¹ and 
the polar molecules begin rotating, trying to align with the constantly changing electric field. The 
field changes before the molecules can complete their rotation, and vibration, also known as 
rotational oscillation, occurs where heat is generated through friction [26,37,40]. At frequencies 
greater than 2450 MHz, the molecules do not have time to start realigning since the electrical 
field changes too rapidly. At frequencies lower than 2450 MHz, the electrical field changes much 
more slowly and the molecules have time to align themselves. In both of these situations, no heat 
is generated [37].  
 
1.7.4 Microwave Heating  
Microwave heating, the transformation of electromagnetic energy in thermal energy, is generated 
from the interaction of the electrical field with polar compounds and solvents. Microwave 
heating can occur in two mechanisms: ionic conductance and dipolar rotation. Ionic conductance 
is the migration of ions under an electric field. Friction is generated due to the interaction of 
migrating ions with the solvent, consequently producing kinetic energy and converting it into 
thermal energy [26]. The migration direction of the ions changes as many times as the electric 
field changes polarity [26,37,39,40]. Dipole rotation is defined by the constant realignment of 
dipolar molecules in a continually altering electric field. As the molecules agitate and collide, 
heat is created [26,37,39,40]. The ability of molecules to align themselves with the field depends 
on the microwave frequency and the viscosity of the liquid [26].  
The efficiency with which a material absorbs microwave energy and transforms it to heat 
depends on its dissipation factor (tan δ). The following equation defines tan δ:  
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tan δ = Ɛ’’ 
           Ɛ’ 
where Ɛ’ represents the dielectric constant (relative permittivity), which measures the capacity of 
a molecule to be polarized by an electric field, and therefore to store potential energy, and Ɛ’’ 
represents the dielectric loss, which measures the efficiency of the conversion of electromagnetic 
energy into heat in a varying electrical field. Only dielectric materials or solvents with permanent 
dipole moments, such as water and methanol, can absorb microwave energy and produce heat 
(table 1) [37]. Non-polar materials, such as hexane, are transparent to microwaves, and thus do 
not generate heat [39]. The more polar the solvent, the greater the dielectric constant and 
therefore, the more efficiently microwave irradiation will be absorbed; allowing the system to 
achieve higher temperatures [26]. For example, as seen in table 1, methanol has a lower 
dielectric constant than water, but a higher dielectric loss, resulting in a higher dissipation factor. 
Thus, methanol may not absorb microwaves as well as water, but it has a better ability to 
dissipate the microwave energy into heat [26,40]. A common solvent for the extraction of polar 
compounds is methanol or a mixture of methanol and water [40]. 
Based on these phenomena, there are three possible mechanisms of MAE [39,42]. First, the 
analyte may be extracted into a solvent (or a mixture of solvents) that strongly absorbs 
microwave energy. Secondly, the analyte may be extracted into solvents with both high and low 
dielectric losses. Third, the analyte may be extracted into a microwave transparent solvent from a 
sample matrix with a high dielectric loss.  
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Table 1: Chemical and physical properties, including dissipation factors, of solvents with 
different microwave irradiation absorbing abilities at 25 °C. 
Solvents Dielectric 
constant  (Ɛ’)  
Dielectric 
loss (Ɛ’’)  
Dipole moment  NLBP (°C)* References 
Acetone 20.7 0.95 2.69 81 26,30,43,44 
Acetonitrile 37.5 1.65 3.44 107 30,44 
Ethanol 24.3 1.625 1.69 103 30,40,44 
Methanol 32.7 15.296 1.70 84 30,40,43,44 
Heptane 1.9 0.00019 <0.01 N/A** 40 
Hexane 1.89 0.000019 < 0.1 80 30,43,45 
2-Propanol 19.9 2.81 1.66 100 30,44 
Ethyl acetate 6.02 0.3 1.78 95 26,43,44 
Water 80 10 1.87 104 30,40,43,44 
* Nucleation limited boiling point 
**Not available 
 
 
1.7.5 Superheating 
A solvent irradiated in a closed-vessel system can reach a temperature higher than its boiling 
point due to the increased pressure and the lack of nucleation sites. This phenomenon is called 
superheating [40,44]. Baghurst and Mingos [44] referred to this temperature as the nucleation 
limited boiling point (NLBP) [44].  
The boiling process depends on nucleation sites, cavities, pits and scratches on the vessel and in 
the solid sample matrix. The formation of bubbles during the boiling process rely on the vapour 
(embryo) trapped inside a crevice by the surrounding liquid. A bubble is created when the 
temperature of the solvent reaches the temperature corresponding to the pressure inside the 
embryo. The growth of the bubble is due to the evaporation of the superheated solvent around 
the bubble. Once the force holding the bubble in place is overcome, the bubble is released and 
boiling begins (figure 2) [44]. 
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The number of active sites depends on the surface of the vessel and/or matrix and the solvent’s 
ability to wet the surface. The larger the number of active sites, the lower the NLBP. Organic 
solvents have good wetting properties, trapping less vapour, forming a lower number of 
nucleation sites and leading to a higher NLBP. On other hand, water has a poor wetting ability 
and therefore a high number of embryo and a lower NLBP (see Table 1 for examples of NLBP) 
[44]. 
 
 
Figure 2: Increasing the nucleation liquid boiling point  
(Baghurst and Mingos, 1992) [44] 
 
 
In conventional heating, a conduction/convection phenomenon occurs where thermal energy is 
supplied externally to the walls of the vessel (conduction) which, in turn, is transferred within the 
liquid (convection). A large part of this heat produced is lost to the environment [29,39]. During 
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microwave irradiation, the matrix or the solvent is directly heated (internal heating), with 
practically no heat lost (in closed-vessel system). This leads to shorter extraction times [37]. 
Therefore, in conventional heating, the superheated solvent layer is only in contact with the 
vessel, as opposed to microwave heating where the bulk solvent is superheated [29,39]. Having 
the bulk of the solvent reach NLBP rather than only the layer adjacent to the vessel is an 
important aspect in understanding the mechanism and efficiency of microwave heating [44]. 
Thus, the rapidity of MAE compared to standard passive extraction also depends on the 
conditions of the surface of the glass vessels and/or the sample matrix and the wetting properties 
of the extraction solvent [44]. 
In 1992, Baghurst and Mingos verified this theory by adding different concentrations of 
detergent to water samples [44]. Results show an enhancement in the wetting ability and a higher 
NLBP, even with the lowest detergent concentration, compared to water only. On the other hand, 
NLBP were reduced when water was added to ethanol samples and when the wetting properties 
of glass were reduced by silylation with trimethylsilyl chloride ((CH3)3SiCl) [44]. Different ways 
to increase the heating rate of a solvent include the addition of small amounts of organic solvent 
with a high dissipation factor to a non-polar solvent, where the heat transfer between the solvents 
is quick, or with ionic liquids by addition of salt to solvents [26]. 
 
1.7.6 Influential Parameters 
1.7.6.1 Extracting Solvent 
The solvent is chosen according to its selectivity for the analyte and its ability to extract and 
dissolve the analyte. The solvent must also be able to absorb microwave energy and should not 
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interact with the matrix [37,39,40]. Many organic solvents are flammable, and when heated, can 
combust or explode. For this reason, great caution must be taken when choosing an extraction 
solvent in order to prevent such occurrences. 
 
1.7.6.2 Solvent Volume 
The solvent volume depends on the type and the size of sample [39]. In comparison to 
conventional extraction techniques, where a high ratio of solvent volume to solid matrix is 
necessary, MAE, on average, requires about ten times less solvent [37,39]. The larger the solvent 
volume, the faster heat is generated, but Mandal [37] and Madej [39] reported lower recoveries 
with larger solvent volumes due to inadequate stirring. 
 
1.7.6.3 Sample Mass 
As the sample mass increases, so does the solvent volume required to ensure the sample is 
immersed throughout the entire irradiation time. Increasing the sample mass and solvent volume 
also increases the extraction time required to achieve maximum recovery [37,39].  
 
1.7.6.4 Extraction Time 
As mentioned previously, extraction time in MAE is much shorter than with conventional 
extraction techniques due to the high rate of heating that may be achieved [37,39]. Increasing the 
irradiation time has been shown to be an insignificant factor, as there was no improvement in the 
extraction efficiency [39]. In some cases, longer irradiation time can even decrease recovery of 
thermolabile compounds [37,40]. The extraction time required is mainly dependent on the ability 
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of the solvent or sample matrix to absorb microwave energy and transform it into thermal energy 
[39]. Another important factor that influences the extraction time is the number of samples or the 
total volume or mass of sample in the oven. Since the power generated is constant, it is 
distributed uniformly throughout the samples; if the number of samples increases, the power 
distributed to each sample will decrease [40]. With a decrease in power comes an increase in 
irradiation time in order to obtain the same yield [40]. 
 
1.7.6.5 Microwave Power 
In general, the higher the microwave power, the shorter the exposure time; however, in some 
cases, high microwave power decreases the extraction efficiency, as it degrades the sample 
[37,39]. Therefore, the power applied should depend on the sample matrix itself and the number 
of samples undergoing simultaneous irradiation. The selection of microwave power can also 
depend on the solvent type. As a solvent’s ability to absorb microwave energy increases, so does 
the temperature. In open-vessel systems, a rapid increase in temperature leads to rapid boiling, 
which in turns reduces the contact between the solvent and the sample, slowing the extraction 
process. In this instance, a lower microwave power is recommended [37,39].  
 
1.7.6.6 Temperature 
The optimal temperature for extraction depends on the nature of the matrix of the sample, the 
stability of the analyte and the extraction solvent [40]. For example, thermolabile compounds 
should not be extracted at high temperature. However, an advantage of high temperature is the 
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increase in analyte desorption and solvent penetration (wetting ability of solvent), resulting into a 
shorter extraction time [37].  
 
1.7.6.7 Moisture 
Water content is an important parameter in the extraction of compounds from plant matrices. 
Due to the polarity of water molecules, a rapid temperature increase can occur [40]. Thus, water 
within the matrix leads to direct heating of the matrix itself as opposed to heating of the matrix 
via solvent surrounding the sample. Similarly to increasing the solvent volume, an increase in 
matrix water content improves analyte recovery [40].   
 
1.7.7 Influence of the Matrix Properties 
The size of the sample particles greatly influences the recovery of compounds. As the particle 
size decreases, the surface area increases, allowing a greater contact between the solvent and the 
sample matrix, and consequently, a better extraction yield with further solvent and microwave 
penetration [37]. Complex matrices have a tendency to generate lower recoveries [39].  
 
1.7.8 Instrumentation 
Two types of microwave ovens exist: multimode and monomode (also called focused 
microwaves). In the multimode configuration, the microwave irradiation is essentially dispersed 
uniformly throughout the microwave cavity. In the single-mode microwave configuration, the 
microwave irradiation is focused on a restricted area of the sample, where a stronger electric 
field is applied [37,40]. Furthermore, microwave systems can be divided into two categories: 
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closed- and open-vessel systems. In both cases, the vessel material should be transparent to 
microwaves and inert to the solvent [37,40].  
 
1.7.8.1 Closed-Vessel Systems 
Since high temperatures (higher than the solvent’s boiling point) and pressures are usually 
reached in closed-vessel systems, these parameters are monitored within the extraction vessel by 
detectors, to prevent overheating and over-pressurization. The vessel material, in these cases 
must also be thermally compatible.  
Closed-vessel microwave systems have many advantages over the open-vessel microwave 
systems, mainly due to their ability to accommodate higher temperatures and pressures. This 
yields shorter extraction times and requires smaller solvent volumes, which in turn increases the 
analytical throughput and makes the technique more environmentally friendly and cost effective 
[37,40]. Also, a larger range of compounds can be extracted, including semi-volatile analytes, 
and the risk of atmospheric contamination and loss due to evaporation is eliminated [37,40]. 
Finally, the reproducibility and accuracy are also higher due to the ability to control the 
temperature and pressure [37]. 
Closed-vessel microwave extractions are limited by the cooling time required after every 
irradiation in order to avoid loss of volatile compounds [37]. Also, for safety reasons, addition or 
removal of solvent and reagent during the operation is not possible. The higher temperature and 
pressure also prevent the extraction of thermolabile analytes and pose safety risks [37,40]. In 
addition, a higher cost is associated with closed-vessel microwaves due to the instrument itself as 
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well as the specific vessel material required as result of the high temperatures and pressures 
attained [40]. 
 
1.7.8.2 Open-Vessel Systems 
Open-vessel systems operate at atmospheric pressure, and therefore do not reach temperatures as 
high as in closed-vessels. In consequence, these systems require longer extraction times.  
One of the main advantages of the open vessel microwave extraction is the increased safety due 
to lower pressure [37,40]. Since a lower temperature is generated, the samples do not require a 
cooling or depressurizing period after irradiation. This technique is also more suitable for 
thermolabile compounds and has a lower cost compared to closed-vessel microwave systems. 
Solvents and reagents can easily be added or removed at any time and the vessels can be made of 
various material compared to closed-vessel [37].  
The limitations of open-vessel microwaves include longer extraction times as a result of lower 
temperatures attained and accounting for required pauses during extractions to limit extraction 
solvent boil-over [37]. In addition, a decrease in precision and lower yields compared to closed-
vessel microwave systems are observed [37].  
 
 
1.7.9 Advantages and Limitations of MAE 
The main advantages of MAE are the significant reductions in extraction time and organic 
solvent consumption, mainly due to the high temperatures and pressures that may be 
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accommodated [30,34,36,37,39,40,46]. Similar observations were made with microwave 
digestion, clean-up and synthesis [28,43]. Compared to conventional extraction techniques, such 
as Soxhlet extraction, MAE can extract multiple samples simultaneously, increasing the 
throughput [30,34,36,46]. Microwave heating also offers homogenous heating throughout the 
sample, creating no temperature gradient due to the direct heating of the solvent or the sample 
matrix as opposed to the conduction/convection heating methods of standard passive extraction 
[40]. Today’s instruments offer partial or complete automation during the analytical process 
which in turn provides better accuracy and precision [37]. MAE is also known to extract trace 
amounts of analyte compared to Soxhlet extraction [37]. Extraction yield and reproducibility are 
typically comparable or higher than those obtained by conventional extraction methods 
[37,40,46]. 
The drawbacks of MAE are the required cooling time for closed-vessel systems, the higher 
instrumental cost and the requirement of solvents and/or matrices that absorb microwave energy 
in order to generate heat [30].  
 
1.7.10 MAE in Forensic Toxicology 
MAE has been used in many different branches of chemistry, such as environmental analysis and 
medicinal chemistry and even the food industries, but its application to forensic toxicology is 
relatively new. Only a few studies have been published in this area. Franke et al. demonstrated 
an increase in recovery of drugs extracted from serum of 22 positive autopsy cases, using MAE 
with organic solvents [41]. Watterson and his group have published reports examining the utility 
of MAE for the extraction of drugs from ground bone [14,47]. Lastly, Fernández reported using 
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microwave energy for the simultaneous extraction of cocaine, CCE, BZE, 6AM, morphine and 
codeine from hair [46]. 
 
 
1.8 Ultrasound-Solvent Extraction 
1.8.1 History and Applications 
The first scientists to describe cavitation were Sir John Thornycroft and Sydney W. Barnaby in 
1894, where strong vibrations and erosion were experienced and observed during the testing of a 
new high speed British Navy ship, The Destroyer, which lead to the formation of cavitation 
bubbles [48,49]. In 1927, Alfred L. Loomis was the first to study the unusual effects of 
sonochemistry; however, it was not until the 1980s that sonochemistry was further explored and 
articles were published where ultrasonic waves were used for mixing and homogenization 
purposes and compared to vortex mixing [50].  
Today, ultrasounds are applied in many different areas including the medical field and industries 
for imaging, cleaning, vaporizing and also in home security alarms [46].  Most importantly, 
ultrasounds have been used in different aspects of chemistry for their physical and chemical 
effects. For example, ultrasounds have been used for reaction acceleration, degassing of liquids, 
slurry dispersion, homogenization, nebulisation, washing, derivatization and extraction 
[47,51,52,53,54,55,56].  
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1.8.2 Ultrasound and Cavitation Theory 
Unlike electromagnetic waves, such as radio waves, infrared, visible, ultra-violet, X-rays and 
gamma rays, which can travel through vacuum, sound waves are mechanical vibrations that 
travel through matter. Ultrasonic waves are sound waves with a frequency range higher than the 
audible range of humans (16 Hz to 20 kHz), ranging from 20 KHz to 10 MHz [49,57]. Sound 
travels throughout matter in series of expansion and compression cycles, producing oscillation 
and promoting solvent penetration in samples. Throughout expansion cycles, the molecules are 
pulled apart, and are pushed together during compression cycles. When expansion occurs in a 
liquid, negative pressures are created at pre-existing weak points called cavities, where the 
vapour and dissolved gases migrate and accumulate forming bubbles. Once the negative pressure 
generated from the oscillation is greater than the tensile strength of the liquid, the bubble 
implodes and cavitation starts [46,47,49]. Cavitation is the rapid process (400 µs) of the 
formation and collapsing of bubbles during the oscillating expansion-compression cycles. It 
produces hot spots (~5000 °C) with a pressure of about 1000 atm due to the compression of 
gases and vapours [46,47,49,58,59]. When micro-bubbles implode, high temperatures and 
pressures are produced by gas and vapour compression that quickly dissipate through the bulk of 
the solvent, increasing the overall sample temperature only slightly and facilitating the analytes 
desorption and solvent penetration [47]. Occasionally, these extreme conditions can also lead to 
the formation of free radicals [49,56,57].  
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1.8.3 Cavitation Next to a Solid 
In a liquid, the bubbles implode in a spherical shape due to the homogeneous surrounding. When 
cavitation occurs next to a solid, the formation and collapsing of a bubble is asymmetrical, since 
the surroundings are not uniform, leading to the formation of a high-speed liquid jet (400 km/h) 
[49]. When a bubble implodes, the potential energy from the expanded bubble transforms into 
kinetic energy and forms a liquid jet that penetrates the bubble [49,51]. The high-speed liquid jet 
penetrates the bubble from the opposite side that is in contact with the solid, towards the solid, in 
some cases fracturing the solid matrix, thus increasing the surface area and solvent penetration 
(figure 3) [49,51,58,60]. The implosion of these asymmetrical bubbles also causes turbulence 
and liquid circulation currents [60]. 
 
 
Figure 3: Cavitation in presence of a solid 
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1.8.4 Ultrasound Solvent Extraction 
The physical effects produced by ultrasounic solvent extraction (USE) (turbulence and liquid 
circulation currents) increase the mass transfer and yield significantly [60]. USE is used as 
opposed to the traditional shaking method or Soxhlet extraction, as it provides a better contact 
between the sample and the solvent by increasing the solvent penetration which, in turn, reduces 
the extraction time and the volume of solvent required for maximum recovery [49,59,61]. It is 
also a good alternative technique for compounds that oxidize in acidic conditions and 
thermolabile analytes [51,61]. 
In environmental chemistry, ultrasound-solvent extraction has been used for the extraction of 
metallic analytes, pesticides, phenolic and aromatic compounds and natural products, from soils, 
sediments, powdered plant materials and foods [51,61].  
 
1.8.5 Influential Parameters  
Overall, the cavitation process is influenced by the extraction solvent, sample mass, solvent 
volume, extraction time, sample particle size, presence of dissolved gasses in the extracting 
solvent, medium temperature and intensity, and frequency of the applied ultrasonic waves 
(power density [W/cm²]) [49,51,58]. Other parameters that apply strictly to water baths are the 
presence of dissolved gases and vapours in the water of the bath, size and thickness of the vessel 
walls and position and number of samples in the bath [58]. Different extraction efficiencies of 
arsenic were observed when positioning the vessels at different places in the water bath and 
when comparing horizontal and vertical vessel positions by Capelo and his research group [58]. 
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1.8.5.1 Extraction Solvent 
The extraction solvent and its characteristics are some of the most important parameters of USE. 
The extraction efficiency depends on the ability of the solvent to extract the analytes from the 
solid and dissolve them, as well as its capacity to absorb and transmit the sound waves. The 
extraction solvent’s surface tension and vapour pressure are important. As both of these 
characteristics increase, the cavitation intensity decreases [60]. Most extraction solvents cited in 
the literature for the extraction of a large variety of compounds include aqueous solvents, such as 
water and buffers and organic solvents, like methanol, ethanol, isopropanol, n-butanol, acetone, 
acetonitrile, ethyl acetate, hexane, dichloromethane and diethyl ether. The extraction solvent for 
USE is analyte dependent and is selected based on its viscosity and polarity, and on the chemical 
structure of the targeted compound [60,62]. 
 
1.8.5.2 Sample Mass and Solvent Volume 
Samples require enough extraction solvent to immerse the matrix at all time. Capelo et al. 
observed no change in extraction efficiency with different solvent volume and sample mass as 
long as the mass-to-volume ratio was kept constant [58].  
 
1.8.5.3 Extraction Time 
The irradiation time required for maximum extraction efficiency depends mainly on the 
extraction solvent, the sample matrix and the power density generated. A greater amount of time 
is required when extracting analytes using a water bath compared to a probe [61].  In general, the 
higher the amplitude of the ultrasound irradiation, the shorter the extraction time required [58]. 
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As the wave frequency is increased, the amplitude (power) must also be increased to keep the 
cavitation energy. Unlike probes, most water bath transducers do not have the ability to change 
the power density or frequency applied. The extraction time should be optimized for each 
analytes to ensure maximum extraction and prevent degradation of sensitive compounds [60,61].  
 
1.8.5.4 Power Density 
Ultrasonic systems usually operate at frequencies of 20, 40 or 80 kHz and power outputs of 50-
700 W. As mentioned above, when increasing the frequency, power must also be increased in 
order to obtain the equivalent cavitation effect. Although bath systems usually function at a fixed 
frequency and power, these parameters can be adjusted in probe ultrasonicators, which are 
designed to deliver constant amplitude [58,60]. As the amplitude of the ultrasonic waves 
increases, so does the cavitation effect. Therefore, a larger power density generates more bubbles 
which, in turn, increase the extraction efficiency [62]. 
 
1.8.5.5 Sample Particle Size 
The smaller the particles in a sample, the more homogeneous the sample will be, allowing a 
better distribution of the analyte through the matrix and therefore, better reproducibility. Smaller 
particles provide greater surface area, allowing a greater contact between the solid matrix and the 
extracting solvent, thus increasing analyte recovery [58]. However, the analyte distribution 
through the material must also be considered. If the analytes reside on the surface of the bone, 
the effect of particle size may be less relevant to the recovery as may be expected if they were 
uniformly distributed within the solid bone. The particle size depends greatly on the sample 
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matrix composition. On the other hand, Capelo et al. observed no significant difference in metal 
recovery from mussel tissue samples when comparing time exposed to ultrasound wave 
irradiation (10 and 120 min) and particle size (< 30 µm and > 300 µm) [58]. 
 
1.8.5.6 Medium Temperature 
As a general rule, when the temperature increases, so does analyte extraction and dissolution. 
However, temperature must also be optimized in order to prevent compound degradation.  
 
1.8.6 Instrumentation 
1.8.6.1 Bath  
A piezoelectric transducer installed in a water bath can create a power density between 1-5 
W/cm². The amount of energy transferred to the sample depends on the dimension of the bath, 
water volume, the position of the transducer, the material and the thickness of the vessel walls, as 
well as the position and number of samples in the bath [51]. For this reason, comparison of 
results obtained from different laboratories is almost impossible.  
The main advantages of ultrasonic baths are their low cost (approximately $1000 US) compared 
to probes ($2000-4500 US) and their higher throughput. For these reasons, ultrasonic baths are 
widely used. In addition, due to the simplicity of the technique, vessels of many different shapes 
and materials can be accommodated [58]. Some of the disadvantages of water baths, that affect 
the reproducibility, are the lack of uniformity in the distribution of the ultrasounds energy and 
the decline in power over time [49,51,58]. The energy generated by the bath water transducer 
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first has to go through the water of the bath and then the vessel walls in order to attain the 
sample; therefore energy is lost at each step which results in less cavitation [49].  
 
1.8.6.2 Probe 
It is well known that probes and horns can generate much more powerful ultrasonic vibrations 
(50-750 W/cm²) [49]. In this situation, the ultrasounds produced are transferred to a metal rod, 
usually made of titanium, which is immersed directly into the sample, preventing energy loss by 
water and vessel wall absorption. Due to the focused ultrasound energy, which generates greater 
cavitation, shorter extraction times are required and a generally higher reproducibility and 
analyte recovery is observed [49,51,58]. Furthermore, the amplitude and frequency can usually 
be modified [51]. Probes are limited by their high cost and their lower sample throughput [58]. 
 
1.8.7 Advantages and Limitations of USE 
USE is a simple and inexpensive substitute technique to conventional extraction methods with 
high extraction efficiencies and yield. This technique requires less extraction solvent and time, 
making it an eco-friendly and high throughput technique [49,58,59,61]. USE is also a less 
aggressive technique compared to MAE and Soxhlet extraction since it operates at a low 
temperature and pressure. Molecular decomposition of sensitive and thermolabile compounds is 
thus minimized [49,59,60,61,62]. Also, unlike MAE, USE is not limited by the extraction solvent 
[49]. 
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The major drawback of USE is the lack of reproducibility from ultrasonication water baths, 
especially between instruments, since the generation and distribution of the ultrasound energy is 
not constant [49,58,61].  
 
1.8.8 USE in Forensic Toxicology 
Ultrasonic solvent extraction is a relatively new application to forensic toxicology, and one that 
has not been applied to the extraction of drugs and drug metabolites from bone. In the past, USE 
has been employed to isolate pesticides from soil samples and for the extraction of drugs from 
hair [63,64].  
 
 
1.9 Drugs of Study 
Drugs most commonly found in forensic toxicological cases include recreational, illicit and 
therapeutic drugs. These drugs include caffeine, nicotine, alcohols (ex: ethanol), cannabinoids 
(ex: marijuana and hashish), opioids (ex: heroin, codeine, morphine and opium), stimulants (ex: 
cocaine, amphetamine), benzodiazepines (ex: diazepam), antipsychotics (ex: chlorpromazine), 
antidepressants (ex: amitriptyline and citalopram) and many more [1,2,3,16 ,65].  
 
1.9.1 Amitriptyline and Nortriptyline 
Amitriptyline (AMI) is a tricyclic antidepressant (TCA), and is part of the first generation 
antidepressants. It was released for clinical use in 1961, and is typically used to treat depression, 
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anxiety disorders, eating disorders and attention deficit hyperactivity disorder (ADHD) 
[66,67,68,69,70,71,72]. AMI has also been used to treat nocturia and enuresis in children and 
more recently, AMI has also been found effective in reducing neuropathic pain, fibromyalgia, 
headaches and severe chronic low-back pain [67,68,73]. TCAs are characterized by the three 
hydrocarbon rings structure linked to an alkylamine chain containing a tertiary or secondary 
amino group at the terminus (figure 4) [66]. 
AMI, 3-(10,11-dibenzo[a,d]-cycloheptene-5-ylidene)-N,N-dimethyl-1-propamine, blocks the 
reuptake of norepinephrine, dopamine and serotonin neurotransmitters associated with the 
regulation of mood and anxiety [18]. AMI is administered orally or intramuscularly (IM); doses 
vary from 25-150 mg for outpatients and up to 300 mg for hospitalized patients [74]. At 
therapeutic concentrations, side effects include anticholinergic effects such as dry mouth, blurred 
vision, drowsiness, sedation, lowered blood pressure, weight gain, sweating, and fatigue. Toxic 
symptoms include cardiac dysrhythmia, severe hypotension, stomach and digestive problems, 
convulsions and central nervous system (CNS) depression [74,75]. Therapeutic and toxic blood 
concentrations in humans are reported in table 2. 
In humans, AMI gets metabolized through cytochrome P450 (CYP) enzymes in the liver into 
more polar metabolites. CYP2C19 is the main enzyme responsible for the N-desmethylation of 
AMI to nortriptyline (NTRIP), an active metabolite, while CYP2D6 is responsible for the 
formation of the hydroxyl metabolites (10-hydroxyamitriptyline, 10-hydroxynortriptyline and 
10-hydroxydinortriptyline) [1,66,75,76]. AMI’s half-life ranges from 8 to 51 h in humans; the 
metabolic pathway is shown in figure 4 [74].  
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Figure 4: Metabolic pathway of amitriptyline and nortriptyline in human [74]. 
 
 
 
Due to its active pharmacodynamic effects nortriptyline, 3-(10,11-dibenzo[a,d]-cycloheptene-5-
ylidene-N-methyl-1-propamine, on its own, is also marketed as an antidepressant [74,78]. The 
pharmacokinetics and pharmacodymanics of NTRIP are similar to those of AMI. 
Neurotransmitter reuptake is inhibited, allowing them to accumulate in the intracellular space 
[66]. NTRIP gets further metabolized by N-desmethylation (CYP2C19) and 10-hydroxylation 
(CYP2D6).   
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Table 2: Pharmacodynamics and pharmacokinetics of selected drugs [74] 
Drugs Amitriptyline Nortriptyline Citalopram Desmethylcitalopram Pentobarbital 
Brand names Elavil, Amitid, 
Endep, Amitril 
Aventyl, 
Sensoval, 
Pamelor, 
Norpress 
Celexa, 
Cipramil 
N/A Nembutal, 
Dorsital, 
Pentobarbitone 
Tablets (mg) 
and solutions 
(mg/mL) 
available 
Tablets: 
10, 25, 50, 75, 
100 and 150  
Solution: 10  
Capsules: 
10, 25, 50 
and 75  
Syrup: 2 
Tablets: 
10, 20 and 
40  
Solution: 2  
N/A Tablets: 15-200  
Solution: 50  
Route of 
administration 
Oral, 
IM 
Oral, 
IM 
Oral, N/A Oral, 
IM, rectal 
Dose range 
(mg) 
25-150  (300 
hospitalized 
patients) 
25-150  10-50  N/A 15-200  (IM) 
Therapeutic 
blood conc. 
(mg/L) 
0.016-0.242  0.014-0.180  0.05-0.4  N/A 1-5  
Side effects Anticholinergic effects: dry 
mouth, blurred vision, 
drowsiness, sedation, lowered 
blood pressure, weight gain 
sweating, fatigue 
Drowsiness, insomnia, nausea, 
weight changes, frequent urination, 
decreased sex drive, anorgasmia, 
dry mouth, fatigue 
Sedation, 
drowsiness, 
lethargy, 
nausea, vertigo, 
vomiting 
Toxic blood 
conc. (mg/L) 
> 0.5  > 0.5  > 3  N/A > 10  
> 1.0  (combined) 
Toxic 
symptoms 
Cardiac dysrythmia, severe 
hypotension, stomach and 
digestive problems, convulsions, 
CNS depression 
Somnolence, nausea, vomiting, 
nystagmus, dilated pupils, 
sweating, tremor, tachycardia, 
migraine, diarrhea, insomnia, 
hypotension 
Drowsiness, 
confusion, 
respiratory 
depression, 
cardiovascular 
depression 
Half life (h) 8-51  15-90  25-40  N/A 20-30  
Bioavailability 
(%) 
30-60  30-70 80  N/A 70-90 
Volume of 
distribution 
(L/kg) 
6-10  20-57  12-16  N/A 0.5-1 
Protein 
binding (%) 
> 90  90 70-80  N/A 20-60  
pKa 9.4 9.7 9.5 N/A 7.9 
References 66-76,81,82  74,77,78 74 
 
Due to its ubiquitous use and narrow therapeutic range, amitriptyline is the most encountered 
TCA in emergency toxicology screening, drug abuse testing and forensic medical examination 
[1,2,66,72]. In addition, drug interactions occur when other drugs with CNS depressant 
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properties, such as ethanol, are taken simultaneously with AMI, causing symptoms from mild 
impairment to respiratory depression, reduced heart rate, coma and death. Toxicity arises when 
ethanol is co-administered, inhibiting P450 enzymes, prolonging the half-life of the drug, 
increasing the AMI plasma concentration during the absorption and distribution phase, and 
preventing elimination [75]. Other possible drug interactions include CYP450 inducers and 
inhibitors, and mono-amine oxidase inhibitors (MAOI). Today TCAs have mainly been replaced 
by newer and safer antidepressants with less severe side effect and lower risks of cardiovascular 
and neuronal toxicity [66,68].    
 
1.9.2 Citalopram and Desmethylcitalopram 
Citalopram (CIT) is part of the third generation antidepressants, the selective serotonin reuptake 
inhibitors (SSRIs), and has been used clinically since the mid 1980s to treat depression, 
obsessive-compulsive disorder (OCD), panic disorder, anxiety, post-traumatic stress disorder, 
smoking cessation and ethanol abuse [19,69,77,78]. CIT, (RS)-1-[3-(dimethylamino)propyl]-1-
(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile, is structurally unrelated to other 
SSRIs and is available as a racemic mixture of R- and S- enantiomers (figure 5), but S-CIT is 
mainly responsible for the SSRI effect, and is now marketed as a single enantiomer drug,  
escitalopram [74,77,78,79]. As the name suggests, SSRIs inhibit the reuptake of serotonin from 
the synaptic cleft to the presynaptic neurons, allowing the postsynaptic neurons to be stimulated 
longer, but has little effect on noradrenaline and dopamine [78]. CIT is administered orally, with 
doses varying from 10-50 mg, and typical blood concentrations of 0.04 - 0.1 mg/L [74]. Mild 
side effects include drowsiness, nausea, frequent urination, dry mouth, and decreased sex drive, 
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while toxic blood concentrations cause somnolence, nausea, vomiting, dilated pupils, tachycardia 
and hypotension – see table 2 for therapeutic and fatal blood concentration range [74].  
Through CYP2C19, CYP3A4 and CYP2C6, citalopram undergoes mono- and di-N-
demethylation to desmethylcitalopram (DCIT) and didesmethylcitalopram (DDCIT) (figure 5). 
Both are pharmacologically active, but less potent than the parent drug, slightly prolonging the 
neuronal activity [74,79]. CIT has a half-life ranging from 25 to 40 h in humans [74]. 
Drug interactions between SSRIs and MAOI can occur by creating an excess of serotonergic 
activity at the CNS and peripheral serotonin receptors. Symptoms of serotonin toxicity include 
increased heart rate, sweating, hyperactive bowel sounds, high blood pressure and hyperthermia. 
The possibilities of drug interactions can occur through many different mechanisms that are 
hepatically metabolized. In addition, the long elimination half-life increases the potential 
interaction with other drugs even after use has been discontinued [77,78].  
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Figure 5: Metabolic pathway of citalopram and desmethylcitalopram [74]. 
 
1.9.3 Pentobarbital 
Pentobarbital (PB) is a short acting barbiturate, first introduced in the early 1930s. It is used as a 
sedative, hypnotic, anticonvulsant for epilepsy, anxiolytic (antipanic or antianxiety agent) and 
veterinary anesthetic and euthanasia agent [74,80,81]. PB was also once used for execution of 
humans in the United States, and to treat insomnia and anxiety, but has now been replaced by 
benzodiazepines due to its low therapeutic index and potential for abuse [81]. On occasion, 
Citalopram	  
(CIT) 
Desmethylcitalopram	  
(DCIT) 
Didesmethylcitalopram	  
(DDCIT) 
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pentobarbital is also used to reduce intracranial pressure, and induce coma in cerebral ischemia 
patients and assisted suicide [80,82].  
Pentobarbital, 5-ethyl-5-(pentan-2-yl)-1,3-diazinane-2,4,6-trione, acts as a non-selective CNS 
depressant (figure 6). The mechanism of action is still not completely understood, but it acts by 
depressing the CNS and inhibiting certain nerve response centres [74,80,82,81]. PB is usually 
administered orally (15-200 mg) and side effects include loss of balance or coordination, nausea 
and headache. As the dose increases, so does the depression of the brain functions; first signs of 
toxicity observed are confusion, shallow breathing and slow heart rate. See table 2 for 
therapeutic and fatal blood concentration range [74].   
PB has a half-life of 20-30 h in humans and undergoes first pass metabolism in the liver. Its 
primary biotransformation is via oxidation into a diastereomeric mixture of alcohols (inert 
metabolites) and secondarily by N-hydroxylation [74,81,83,84,85]. 
 
 
Figure 6: Chemical structure of pentobarbital [74]. 
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Drug interactions with barbiturates occur with other CNS depressants, such as ethanol, opioids, 
antihistamines, and sedative/hypnotic agents, where additive effects result in slower brain 
activities, cardiovascular instabilities and respiratory depression [86].  
 
 
1.10 Preparation of Solid Samples 
Many techniques have been used for the detection and quantification of these five drugs in the 
past, but prior to analysis, sample preparation, such as liquid-liquid extraction (LLE) or solid-
phase extraction (SPE), is required to clean up and reduce the matrix effects created from its 
complex biological matrix [18,67,69,72,76,77,78,86,87]. While LLE used to be the traditional 
sample preparation method, SPE is now predominant in the literature. 
Two types of SPE columns have been used to extract these drugs. Reversed-phase SPE is the 
least selective mechanism and will retain most molecules with any hydrophobic character by 
Van der Waals forces and dipole-dipole interactions, while mixed-mode columns retain 
substances by both hydrophobic and electrostatic interactions [19,69,87,88,89]. The literature 
shows a tendency towards mixed-mode columns because of its higher selectivity and the ability 
to extract multiple analytes with different chemical properties (acidic, neutral and basic) all in 
one column. Using this type of column, at pH 6, weakly acidic compounds, such as 
pentobarbital, remain non-ionized and are retained to the column by hydrophobic interactions. 
On the other hand, strongly basic compounds, such as AMI, NTRIP, CIT and DCIT, are 
protonated and retained by electrostatic interactions [87]. The column can then be washed with 
mixtures of aqueous and water-miscible organic solvents at low pH to prevent the loss of basic 
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compounds during the first elution. At this point, PB can be eluted with a polar solvent and 
subsequently the antidepressants are eluted by increasing the pH with strong NH4OH, rendering 
them neutral, along with a less polar organic solvent [87]. 
 
1.11 Analysis of DCIT, CIT, NTRIP, AMI and PB 
The identification of these five analytes has been performed by many different methods 
including immunoassay [19,66,68], liquid chromatography with a diode array detector (HPLC-
DAD) [66,67,68,71,72,78], or mass spectrometry (LC-MS) [66,72] and gas chromatography 
(GC) with electron impact (EI) or chemical ionization (CI) and MS [19,66,67,72,78], flame 
ionization detector (FID) [19,48,90], or nitrogen-phosphorous detector (NPD) [19,69,91]. 
 
 
1.12 Use of Experimental Animals in Forensic Toxicology Research 
The use of human tissue for forensic research is often impossible for legal reasons. The only way 
human tissue can be acquired is through autopsy, in which important information such as history 
of drug use and dose are unknown. In addition, due to legal restrictions, using autopsy tissue in 
research could cause problems in some jurisdictions. For these reasons, animal models are used. 
Important variables such as the drug exposure, dose, route of administration, delay between drug 
administration and death, and post-mortem circumstances can be controlled. Furthermore, drug 
properties like distribution between tissue types, accumulation and analytical method 
development can easily be understood and developed using animal models. The disadvantage is 
its limited applicability to human cases.  
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1.13 Stability of Drugs in Bone during Decomposition 
Because of the chemical, biological and physical changes occurring to a corpse during 
putrefaction, forensic toxicologists must consider the possibility of drug degradation. During 
putrefaction, various changes in bone occurs, including exchange of ions, uptake of circulating 
organics and microbiological attack; in turn, this results in the breakdown of collagen and 
alteration and leaching of the mineral matrix [92]. In addition, bone damage, such as ante-
mortem trauma or post-mortem animal scavenging, can increase bone porosity, leaving the drugs 
and metabolites more vulnerable to environmental factors and biochemical aspects, such as 
evaporation, release from binding site and drug or protein degradation [10].   
Unfortunately, little information is available in the literature about drug stability in skeletal 
tissue, but many reports show the detection of a variety of drugs from skeletal tissue after long 
periods of decomposition in outdoor conditions or burial. McIntyre et al. [2] were able to detect 
12 different analytes, covering a wide variety of drugs, from 36 cases, using the fresh mid-
femoral bone. Drugs detected include antidepressants like mianserin, moclobemide, sertraline 
and TCAs (amitriptyline, doxepin and dothiepine), antipsychotics such as chlorpromazine, 
thioridazine and clozapine, and benzodiazepines like diazepam, oxazepam and temazepam [2]. 
Levels of diacetylmorphine and its metabolites, 6-acethylmorphine and morphine, from fresh 
mice bone were compared to those buried in open air at room temperature for 2 months, with no 
significant difference observed in analyte recovery [3]. Midazolam was detected in buried mice 
bone and diazepam and its metabolite nordiazepam were observed in fresh rat bone, as well as 
skeletonised porcine bone that was left outdoors for 2 years [65,13,14,93]. In contrast, a paper 
reports 54 % morphine loss in human thigh bone after 1 year burial [16]. Other drugs such as 
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methamphetamine and amphetamine were detected in bone stored for 2 years in open air and in 
rabbit bone after 2 years of storage in tap water at room temperature, while aminopyrine was 
detected in remains estimated to be 2-5 years old [3,15,94]. It appears drug stability in 
decomposing skeletal tissue may be drug dependent.   
It has been demonstrated by many that drug detection from this unusual tissue is possible, but 
that the interpretation of analytical results remains uncertain. Cases where bone would be used as 
samples for toxicological analysis would often have no conventional fluids or tissue available. 
For this reason, research of drug deposition and analysis from bone should also be performed on 
nearly completly skeletonised remains, as opposed to fresh bone [47].  
 
 
1.14  Goal of Research 
For the purpose of this research, the bones of a pig (Sus domestica) were donated from the 
Franklin County Coroner’s Office in Ohio. The original research investigated the temporal fate 
of drugs in decomposing porcine tissue [95]. Pigs were selected due to their resemblance in 
digestive and cardiovascular physiology to humans, and their comparable size. The original 
study was performed in accordance with the National Research Council’s “Guide for the Care 
and Use of Laboratory Animals” and was approved by the ILACUC, The Ohio State University, 
Columbus, OH [95]. 
The main goal of this research was to characterize and optimize new assisted extraction methods 
(microwave-assisted extraction and ultrasonic solvent extraction) for the extraction of selected 
drugs and metabolites from skeletal tissue, and compare them with the standard extraction 
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method, passive extraction. Samples were analyzed by gas chromatography-mass spectrometry 
or ultra performance liquid chromatography with a diode array detector. The effect of different 
variables on the extraction yield and rate was examined, including the effect of extraction 
solvent, sample mass, extraction time, solvent volume, microwave power and the effect of the 
presence of gas in solutions undergoing ultrasonication. In addition, other steps in sample 
preparation were optimized: different solutions and times were tested for protein and lipid 
precipitation and different columns as well as column washes were tested for SPE.  
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Chapter 2 
2 Material and Methods 
2.1 Chemicals 
Drug standards (Cerilliant, Round Rock, TX) were obtained as 1 mg/mL methanolic solutions 
and diluted as required. Trimethylphenyl ammonium hydroxide (TMPAH) was purchased from 
United Chemical Technologies (Bristol, PA). Methanol (MeOH) and ethyl acetate (EA), used in 
drug extraction, were reagent grade and purchased from EMD chemicals (Gibbstown, NJ). 
Acetonitrile (ACN), used in UPLC-DAD analysis, was HPLC grade and purchased from EMD 
chemicals (Gibbstown, NJ). All other chemicals were reagent grade and obtained from EMD 
chemicals (Gibbstown, NJ). 
  
 
2.2  Animals and Drug Administration 
Vertebral bone of a Yorkshire/Hampshire cross-breed pig used in a previous study investigating 
the temporal fate of drugs in decomposing porcine tissue was used throughout this work [95]. 
Pigs for the study were purchased from Kidron Auction (Kidron, Ohio) and weighed between 
120 and 180 pounds (55 and 82 kg). The drug cocktail administered (by gavage) to this particular 
pig contained amitriptyline (75 mg/kg), citalopram (7 mg/kg), diazepam (7.5 mg/kg) and 
morphine (0.8 mg/kg). Drug reference standards and drug cocktail preparation can be found in 
the original report [95]. The animals were anaesthetized with pentobarbital (30 mg/kg, IP) 4 
hours after drug administration. Once sedated, the pigs were sacrificed with 10 mL Beuthanasia-
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D® (390 mg/mL sodium pentobarbital and 50 mg/mL sodium phenytoin (IC) Schering-Plough 
Animal Health, Union, NJ) [95]. 
  
 
2.3  Bone Preparation 
Pig remains were left to decompose in a secure rural location in Ohio for approximately 2 years 
before the collection of skeletal tissues. Bones were separated according to their anatomical 
location. Drug-free porcine bone, donated by Costco Wholesale Corporation, was used as matrix 
simulation for the stability study and negative controls. Control bones were buried in biologically 
active soil (Selection Garden Soil enriched with Compost) for approximately 1 month (in an air 
tight container) and further boiled for approximately 40 hours in water in order to remove as 
much fatty tissues as possible. Both control and drug positive bones were washed with distilled 
water, methanol and acetone (10 mL) to remove soil and other surface contaminants; wash 
solutions were not analyzed. Bones were then crushed manually in a plastic bag with a mallet 
prior to being ground to powder with a domestic grinder (figure 7). Samples were analyzed for 
amitriptyline (AMI), nortriptyline (NTRIP), citalopram, (CIT), desmethylcitalopram (DCIT), and 
pentobarbital (PB). 
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Figure 7: Steps in the sample preparation for the extraction of select drugs and metabolites 
from skeletal tissue 
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Prior to optimizing the solvent extraction steps, the protein and lipid precipitation technique, 
along with the SPE, were optimized by examining the effect of different precipitation solvent, 
storage time, SPE column, and columns washes on the analyte recovery.   
 
 
2.4 Optimization of Solid-Phase Extraction (SPE) 
2.4.1 SPE Column Comparison 
The influence of different SPE columns on the extraction yield was investigated. Samples (n = 2) 
spiked with 100 ng/mL of PB and the antidepressants, as well as a negative control (n = 1), were 
made of matrix-matched bone extract, also called bone tissue extract (BTE, 1 mL), a solution of 
decomposed soft tissue and extracted bone homogenized in phosphate buffered saline at pH 6 
(PBS6). Based on the results from the protein and lipid precipitation section, PBS6 (0.1 M, pH 6, 
3 mL) and ACN:MeOH (1:1 v/v 3 mL) was added before samples were vortexed and stored at -
20 °C for 1 h. Samples were centrifuged (4000 RPM, 10 min) and supernatant was removed and 
evaporated to approximately 1 mL under a gentle stream of air at 70 °C. Samples were diluted to 
4 mL with PBS6 and acidified with 200 µL of glacial acetic acid before loading.  
Samples were extracted with CleanScreen CSDAU mixed-mode columns (200 mg, United 
Chemical Technologies, Bristol, PA), CleanScreen XCEL 1 columns (130 mg, United Chemical 
Technologies, Bristol, PA) or Strata XC columns (60 mg, Phenomenex Inc., Torrance, CA). 
Columns were conditioned with methanol, distilled water and PBS6 (3 mL). Samples were then 
loaded by gravity and columns were sequentially washed with PBS6 (3 mL) and acetic acid (0.1 
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M, 3 mL). Columns were dried under vacuum (10 in Hg, 5 min) before a final methanol wash (3 
mL), where PB was eluted and collected. Columns were then dried under vacuum (15 inHg, 10 
min) and DCIT, CIT, NTRIP and AMI were eluted using a mixture of ammonium 
hydroxide:isopropanol:EA (3:17:80, 2 x 3 mL). All extracts were evaporated to complete dryness 
under a gentle stream of air at 70 °C. 
 
2.4.2 Effect of Hexane Wash 
Based on the evaluation of the different SPE columns, a second set of extractions was undertaken 
to establish the influence of a hexane wash step during the extraction on the level of interfering 
compounds directly affecting the extraction yield. Samples (n = 2) containing 100 ng/mL of PB 
and antidepressants, and negative control (n = 1), were made of BTE (1 mL). Samples were 
treated as mentioned in 2.4.1 SPE column comparison section for the precipitation of proteins 
and lipids. Samples were centrifuged (4000 RPM, 10 min) and supernatant was removed and 
evaporated to approximately 1 mL under a gentle stream of air at 70 °C. Samples were diluted to 
4 mL with PBS6 and acidified with 200 µL of glacial acetic acid before loading.  
Samples were extracted with CleanScreen CSDAU mixed-mode columns (200 mg, United 
Chemical Technologies, Bristol, PA), based on the results of the SPE columns comparison. Half 
the samples were extracted as mentioned in the previous section, while the other half were 
conditioned and loaded the same way, but were washed with PBS6 (3 mL) and acetic acid (0.1 
M, 3 mL) before they underwent vacuum drying (10 inHg, 5 min). Columns were sequentially 
washed with hexane (3 mL) and dried under vacuum (15 inHg, 10 min) before a final methanol 
wash (3 mL), where PB was eluted and collected. Columns were then dried under vacuum dried 
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(15 inHg, 10 min) and antidepressants were eluted using a mixture of ammonium 
hydroxide:isopropanol:EA (3:17:80, v/v/v, 2 x 3 mL). All extracts were evaporated to complete 
dryness under a gentle stream of air at 70 °C. 
 
 
2.5 Optimization of Protein and Lipid Precipitation 
2.5.1 Effect of Solvent 
The influence of different protein and lipid precipitation solutions [acetonitrile (ACN):MeOH 
(1:1 v/v), ACN, acetone: MeOH (1:1 v/v) and acetone] on the extraction yield was investigated. 
Samples (n = 3) containing 100 ng/mL of CIT, DCIT, AMI, NTRIP and PB, and a negative 
control (n = 1), were made of BTE (1 mL). A total of 16 samples were prepared. Secobarbital 
(SB, 50 ng) and desipramine (DMI, 250 ng) were added as internal standards (ISTDs) for PB and 
the antidepressants, respectively. PBS6 (0.1 M, pH 6, 3 mL) and one of the different 
precipitation solutions (3 mL) were added before samples were vortexed and stored at -20 °C for 
1 h to precipitate proteins and lipids.  
 
2.5.2 Effect of Time 
Based on the results of solvents during the protein and lipid precipitation, a second set of 
extractions was undertaken. The influence of different storage times at -20 °C to precipitate 
proteins and lipids on the extraction yield was investigated. Two drug concentration sets were 
used: PB, CIT and DCIT were observed at 50 and 1000 ng/mL, and AMI and NTRIP were 
observed at 100 and 2500 ng/mL (low and high concentrations, respectively). Samples (n = 3) 
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and negative control (n = 1) were made of BTE (1 mL). A total of 16 samples were prepared. 
PBS6 (0.1 M, pH 6, 3 mL), ACN:MeOH (1:1, v/v, 3 mL) and ISTDs were added before samples 
were vortexed and stored at -20 °C for 1 or 24 h of incubation to precipitate proteins and lipids.  
 
 
2.6 SPE Method Validation – Precision and Linearity 
The precision of the analyte response ratio (RR) was measured as the coefficient of variation (% 
CV):  
RR = Peak Area Analyte 
              Peak Area ISTD 
 
% CV =  Standard Deviation   x 100 
  Mean 
 
Analytes were measured in replicates (n = 8) from spiked BTE, in order to determine method 
precision.  
The range of concentrations assayed was 5-2000 ng/mL for PB, DCIT and CIT and 5-5000 
ng/mL for NTRIP and AMI. Based on the SPE protocol used, where the final sample volume 
immediately prior to SPE is 1 mL, these ranges correspond to 5-2000 ng/g and 5-5000 ng/g, 
respectively. All points on curves were prepared in 1 mL of BTE. Samples then underwent lipid 
and protein precipitation and SPE as mentioned above. The limit of quantitation (LOQ) was 
determined as the lowest concentration following validation criteria of precision (% CV smaller 
than 20) and accuracy and the cut off level was the lowest concentration assayed that did not 
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meet those criteria while still detecting the analytes. The cut off level and LOQ were determined 
with replicates (n = 9) of 5, 10 and 25 ng/mL made from drug free BTE. 
 
 
2.7  Drug Stability 
The stability of all five drugs was examined, for passive, microwave and ultrasonic extraction, in 
both MeOH and EA. Samples containing the set of analytes at one of two different 
concentrations in 10 mL of solvent were added to control bone (2 g). The samples then 
underwent passive incubation, microwave irradiation or ultrasonication. Two drug concentration 
sets were used for each analyte: PB, CIT and DCIT at 200 and 2000 ng/mL, and AMI and 
NTRIP at 500 and 5000 ng/mL (low-to-mid and high concentrations, respectively). These 
concentrations were chosen based on prior extractions made from samples of the same vertebral 
bone [93], where higher concentrations of AMI and NTRIP were observed. Samples (n = 3) were 
weighed in screw-cap test tubes and a drug-free sample was included as quality control, for a 
total of 42 samples for all extraction methods. The response ratio was used to determine the 
stability of each drug, when comparing the RR of a sample exposed to the extraction method 
after different time periods.  
 
2.7.1 Standard Passive Extraction 
Samples undergoing passive extraction were vortexed and incubated on a hot plate at 50 °C (± 1-
2 °C) for a total of 96 h. Every 24 h, 1 mL of solvent was removed from each sample and 
evaporated to complete dryness under a gentle stream of air at 70 °C. 
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 2.7.2 Microwave-Assisted Extraction (MAE) 
Samples prepared for MAE were vortexed before microwave irradiation in a household Danby 
microwave oven DMW1153W (1100 W, 2450 MHz) equipped with a turntable for a total of 30 
min in successive intervals of 10 s. All test tubes were manually stirred between 10 s irradiation 
interval to ensure mixing of solvent, to increase the surface area the solvent had in contact with 
the bone and to release any dissolved gases in the order to prevent boiling. A volume of 1 mL 
was removed from each sample at pre-determined times (3, 6, 9, 12, 15, 21 and 30 min) and 
evaporated to complete dryness under a gentle stream of air at 70 °C. 
 
2.7.3 Ultrasound Solvent Extraction (USE) 
Samples to be extracted by USE were first vortexed prior to sonication in a bath sonicator (VWR 
150T Aquastar, VWR Canlab, Mississauga, ON) for a total of 90 min. A volume of 1 mL was 
removed from each sample at pre-determined times (10, 30, 45, 60 and 90 min) and bath water 
was also changed every 30 min in order to reduce the influence of bath heating on the extraction 
process. Samples were treated in the same manner as indicated above.  
 
 
2.8  Optimization/Characterization of Drugs Extraction from Bone 
2.8.1 Effects of Solvents, Sample Mass and Extraction Time 
Drug extraction was performed by adding 10 mL of solvent (MeOH or EA) to 1 or 2 g (n = 3) of 
ground vertebrae. A drug-free (n = 1) sample of porcine bone was also weighed into a screw-cap 
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glass test tube for each weight and solvent, for quality control. A total of 64 samples were 
weighed, where 32 were incubated (16 in each short and long passive incubation intervals), 16 
were irradiated and 16 were sonicated under the same conditions as described above. 
 
2.8.1.1 Standard Passive Extraction 
Samples extracted passively were divided into two groups based on the incubation time – long 
term intervals and short term intervals. All samples extracted passively were incubated for a 
predetermined period of time after which the supernatant solvent was recovered, bones were 
sequentially washed with two 5 mL of the same solvent before a new 10 mL was added in order 
to monitor the rate of extraction. The washes were pooled with the initial supernatant; samples 
were then completely evaporated at 70 °C under a gentle stream of air. Samples submitted to 
long interval passive extraction were incubated for a total of 96 h, where the solvent was 
removed and bones were washed every 24 h. The samples submitted to the shorter term of 
passive incubation were recovered and washed after 3, 6, 10, 15, 21, 30, 45 min, 1, 1.5, 3, 6, 12, 
18, and 24 h. 
 
2.8.1.2 Microwave-Assisted Extraction 
Samples extracted by MAE were irradiated for a total of 30 min. After 3, 6, 9, 12, 15, 21, and 30 
min, the solvent was removed and samples were treated in the same manner as the samples 
extracted passively.  
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2.8.1.3 Ultrasound Solvent Extraction 
Samples extracted by USE were submitted to ultrasonic agitation for a total of 90 min. After 10, 
30, 45, 60 and 90 min, the solvent was removed and samples were treated in the same manner as 
the samples extracted passively and by microwave irradiation.  
 
2.8.2 Effect of Solvent Volume 
Based on the results of experiments examining the influence of the extraction solvent, sample 
mass and extraction time on the extraction yield, a second set of extractions was undertaken to 
investigate the influence of solvent volume on the analyte recovery. Pig bone (1 g, n = 3) and 
control bone (1 g, n = 1) were weighed into screw-cap glass test tubes and 5, 10 or 15 mL of 
methanol was added before passive incubation, irradiation or sonication. A total of 36 samples 
were prepared. 
The passive incubation, irradiation, sonication and solvent recovery was performed in the same 
manner as mentioned in the 2.8.1 Effect of Solvent, Sample Mass and Extraction Time section, 
but the samples were incubated for a total of 72 h, irradiated for 15 min or sonicated for a total of 
45 min only. 
 
2.8.3 Effect of Microwave Power 
The influence of microwave power on the extraction yield was investigated. This extraction set 
was based on the evaluation of the extraction solvent, sample mass, extraction time, and solvent 
volume. Samples of pig bone (1 g, n = 3) and control bone (1 g, n = 1) were weighted into screw-
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cap test tubes and 5 mL of methanol was added before microwave irradiation. A total of 16 
samples were prepared.  
Samples were irradiated for a total of 15 min at a percent power of 100, 80, 50 or 20 %. Solvent 
was recovered and samples were treated in the same method as mentioned in the two previous 
sections.  
 
2.8.4 Effect of Presence of Gas in Water Bath and Extraction Solvent 
Based on the results of experiments examining the influence of the extraction solvent, sample 
mass, extraction time, and extraction solvent volume, a fourth set of extractions was undertaken, 
where the influence of dissolved gasses in bath water and extraction solvent on the extraction 
yield was investigated. The bath water of the sonicator and methanol (extraction solvent) were 
degassed by pressure reduction (vacuum 15 inHg, 10 min). Pig bone (1 g, n = 3) and control (1 g, 
n = 1) were weighed in screw-cap test tubes and 5 mL of methanol (either subject to 
degasification or not) was added before ultrasonic agitation. A total of 16 samples were prepared. 
Table 3 demonstrates the four conditions the samples were subjected to. Solvent was recovered 
and samples were treated in the same manner as mentioned in the section 2.8.1 Effect of Solvent, 
Sample Mass and Extraction Time, but the samples were sonicated for a total of 45 min only. 
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Table 3: Conditions for samples subjected to USE, investigating the effects of presence of 
gas in water bath and extraction solvent 
Samples Degassed bath water Degassed methanol 
Ctrl and triplicates of pig 
vertebrae (G H2O + G MeOH) 
  
Ctrl and triplicates of pig 
vertebrae (Dg H2O + G MeOH) *  
Ctrl and triplicates of pig 
vertebrae (Dg MeOH + GH2O) 
 
* 
Ctrl and triplicates of pig 
vertebrae (DG H2O + Dg MeOH) * * 
 
 
2.9 Protein and Lipid Precipitation and SPE 
After the solvent extraction was performed by one the three techniques, all samples were subject 
to protein and lipid precipitation and SPE before analysis by GC-MS or UPLC-DAD.  
All dried samples were treated in the same manner. First PBS6 (0.1 M, pH 6, 3 mL) and ISTDs 
(50 and 250 ng of SB and DMI, respectively) were added. Based on the results from the section 
2.5 Optimization of Protein and Lipid Precipitation, 3 mL of ACN:MeOH (1:1, v/v, 3 mL) were 
added before samples were vortexed and stored at stored at -20 °C for 1 h to precipitate proteins 
and lipids. Samples were centrifuged (4000 RPM, 10 min) and supernatants were removed and 
evaporated to approximately 1 mL under a gentle steam of air at 70 °C. Samples were diluted to 
4 mL with PBS6 and acidified with 200 µL of glacial acetic acid before loading. SPE was 
performed in the same manner as section 2.4 Optimization of SPE where samples were extracted 
with CleanScreen CSDAU mixed-mode columns (200 mg, United Chemical Technologies, 
Bristol, PA). Columns were conditioned with methanol, distilled water and PBS6 (3 mL). 
Samples were then loaded by gravity and columns were sequentially washed with PBS6 (3 mL) 
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and acetic acid (0.1 M, 3 mL). Columns were dried under vacuum (10 in Hg, 5 min) before a 
final methanol wash (3 mL), where PB was eluted and collected. Columns were then dried under 
vacuum (15 in Hg, 10 min) and antidepressants were eluted using a mixture of ammonium 
hydroxide:isopropanol:EA (3:17:80, 2 x 3 mL). All extracts were evaporated to complete dryness 
under a gentle stream of air at 70 °C. 
 
 
2.10 GC-MS Analysis of PB 
The dried methanolic extracts were reconstituted in 100 µL ethyl acetate and 50 µL of a 
derivatizing agent (TMPAH, 50 µL) was added to perform flash methylation of the PB analytes 
before analysis by GC-MS. Extracts were transferred to the autosampler vials and analyzed on a 
PerkinElmer Clarus 600C GC-MS (PerkinElmer LAS, Shelton, CT) in the selected ion 
monitoring (SIM) mode, using electron impact ionization. A ZB-Drug-1 column (15 m x 0.25 
mm x 0.25 µm, Phenomenex Inc., Torrance, CA) was used for separation and electron energy of 
70 eV was used. Ions monitored were m/z 112, 169 and 184 (PB), and m/z 181, 195 and 196 
(SB), where the ions in bold font were used for quantitative analysis. Aliquots (2 µL) were 
introduced into the injector which was maintained at 250 °C. The initial GC oven temperature 
was set to 60 °C and held for 3 min, before it was increased to 160 °C, at a rate of 100 °C /min. 
The temperature was then increased to 220 °C at a rate of 10 °C /min. Finally, the oven 
temperature ramp was set directly to 300 °C and held for 3 min. The total GC-MS run was 
approximately 20 min. 
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Positive analyte detection was based on two factors: retention time (within 3 standard deviation 
of standard samples) and peak area ratios of quantitative to qualifier ions (within 20 % of 
standard samples). 
 
 
2.11 UPLC-DAD Analysis of DCIT, CIT, NTRIP and AMI 
The dried SPE extracts were reconstituted in 500 µL of 0.1 % formic acid in 10:90 ACN:Ultra-
pure water (A). Samples were centrifuged (13 000 RPM, 10 min) and supernatants were 
transferred to autosampler vials. Chromatographic separation was performed on an Acquity™ 
UPLC system (Waters Corp., Milford, MA) with a diode array detector DAD. A Kinetex C18 
column (100 mm x 2.1 mm x 2.6 µm, Phenomenex, Torrance, CA) was used for analyte 
separation. The column temperature was held at 50 °C and separation was isocratic, using a 
mobile phase composition of 80:20 A:B (A: 0.1% formic acid in 9:1 acetonitrile:water; B: 
acetonitrile). The injection volume was 10 µL. The mobile phase flow rate was held constant at 
0.300 mL/min for a total run time of 5 min. UV spectra were collected from 210-400 nm. 
Quantitative peak area comparisons were made using 240 nm for DCIT CIT, AMI and NTRIP, 
and 290 nm for DMI. 
Positive analyte detection was based on two factors: retention time (within 3 standard deviation 
of standard samples) and UV spectrum (compared to spectrum of standard samples). 
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2.12 Statistical Analysis 
The coefficient of variation (% CV) was used to measure reproducibility. Statistical analysis of 
the data was performed using StatPlus (2009 software, AnalystSoft Inc.). The mass-normalized 
response ratio (RR/m) for each extraction parameter studied was analyzed using two techniques; 
ANOVA (one-way) with Tukey’s post-hoc analysis to assess differences between group means, 
and the validation criterion of ± 20 % mean variability to see if there is any overlap to confirm 
the statistical difference. A p value < 0.05 was recognized as statistically significant.  
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Chapter 3 
3 Results and Discussion 
The main purpose of this work was to optimize and compare the performance of microwave-
assisted extraction and ultrasonic solvent extraction methodologies to isolate drugs and 
metabolites from skeletal tissue in relation to a standard passive extraction. The effect of 
multiple variables, such as extraction solvent, sample mass, extraction time, solvent volume, 
microwave power and the effect of presence of gas in solutions undergoing ultrasonication on the 
extraction yield and rate were examined. Additionally, other sample preparation steps, such as 
the lipid and protein precipitation and SPE were also optimized. 
 
 
3.1 Use of Animal Models 
In the original research where this pig was used, pigs were selected due to their similarities to 
humans, especially in size and digestive and cardiovascular physiology [95]. Important 
parameters such as drug, dose, time between dose and death, and post-mortem environment can 
be controlled with animal models, unlike human models where drug history is usually unknown. 
As a result of the numerous physiological differences between humans and animals, it is 
important to note that animal studies should be used to develop analytical methods and to 
observe trends, but that levels obtained from animal models cannot be directly extrapolated to 
human cases.   
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3.2 Use of Skeletal Tissue in Forensic Toxicology 
Although research laboratories have been looking at different techniques to isolate drugs and 
metabolites from skeletal tissue for the last decade, forensic toxicology laboratories still do not 
analyze bone for drugs in cases [11,12,13,14,22,47,93]. To help in the death investigation, this 
complex matrix would only be analyzed when conventional tissues, such as blood, urine and 
vitreous humor, are unavailable. The process of extracting the analytes from the solid matrix into 
solution can be challenging and time consuming.  
 
 
3.3 Data Treatment 
Drug recovery from bone cannot be accurately measured using methods standard to forensic 
toxicology laboratories. Here, data collected from GC-MS and UPLC-DAD are reported as 
mass-normalized response ratio (RR/m) rather than absolute concentration (e.g., ng/g). From the 
GC-MS, the response ratios of PB were calculated from the peak area of PB at a m/z of 169 
relative to the peak area of SB at a m/z of 196. The RR of the antidepressants was determined by 
the peak area of a drug at 240 nm relative to the peak area of DMI at 290 nm. The value RR/m is 
proportional to analyte concentration, allowing for the comparison of relative drug levels 
obtained through different extraction methods and observing the influence of multiple 
experimental parameters on the recovery. Data are reported this way because the determination 
of absolute drug concentration in bone is complex since drug recovery from bone is 
indeterminable, given that bone cannot be spiked homogeneously, and there are no standardized 
methods of sample preparation for this tissue type. Concentration measurements may therefore 
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be misleading, since reported drug concentration from a given bone may vary between 
laboratories as isolation techniques may differ from one another (i.e. ground versus bone slivers) 
[2,77]. Other than the extraction method, the recovered drug level can vary depending on the 
anatomical location of the bone (ex: central versus peripheral bones) and even within a bone (ex: 
epiphyseal versus diaphyseal) [11,12,13,96]. Given that the purpose of this work was to compare 
the performance of different extraction methods, the RR/m parameter was selected as an 
appropriate measure to compare analytical responses of different samples.  
 
 
3.4 Optimization of Solid Phase Extraction (SPE) 
Optimization of the solid-phase extraction method was completed by examining the effect of 
SPE column and hexane wash on the extraction yield.  
 
3.4.1  SPE Column Comparison 
Three different solid-phase columns were compared using samples containing 100 ng/mL of all 
analytes. Figure 8 demonstrates no significant difference in yield between SPE columns. The 
UCT Clean screen column was chosen based on its lower cost.  
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Figure 8: Comparison of solid-phase extraction column 
 
3.4.2 Effect of Hexane Wash 
Based on the results of the prior evaluation, a second set of extractions was performed to 
examine the influence of a hexane wash step during the SPE on the extraction yield. At first 
view, the results showed a major decrease in background noise, which seemed promising. Upon 
further examination, it seemed the analyte signals had also decreased along with background 
noise. By comparing the peak areas (indicated below the retention time in figure 9), the loss of 
analytes with the hexane wash is clear. 
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Figure 9: UPLC-DAD of DCIT, CIT, NTRIP, and AMI (250 ng of DMI as ISTD) without a 
hexane wash (A) and with hexane wash (B) 
 
 
3.5 Protein and Lipid Precipitation  
Optimization of the lipid and protein precipitation method was carried out by examining the 
effect of solvent and time period stored at -20 °C on the protein and lipid precipitation step.  
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3.5.1 Effect of Solvent 
Four different precipitation solutions were examined to optimize the extraction yield, 
ACN:MeOH (1:1 v/v), ACN, acetone:MeOH (1:1 v/v) and acetone. Samples (n = 3) were made 
of 1 mL BTE spiked with 100 ng/mL of all analytes, where no significant differences were 
observed for all precipitation solutions (figure 10). The ACN:MeOH mixture was chosen for 
consistency purposes since prior methodology, such as the validation, was performed with this 
mixture. Due to lower cost of acetone, the acetone or acetone:MeOH solutions should be 
considered as a precipitation mixture in future research.  
	  
 
Figure 10: Comparison of solvent for protein and lipid precipitation 
 
 
 
3.5.2 Effect of Precipitation Time 
Furthermore, the lipid and protein precipitation step was optimized by observing the influence of 
storage time at -20 °C to precipitate proteins and lipids on the extraction yield of sample at low 
and high analyte concentrations. Samples (1 mL) containing 50 or 1000 ng/mL of PB, DCIT and 
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CIT and 100 or 2500 ng/mL of NTRIP and AMI were subject to 1 or 24 h of storage. No 
significant difference was calculated between the set of samples (figure 11).  
 
 
Figure: 11: Comparison of storage time for lipid and protein precipitation of (A) 50 and 
100 ng/mL, and (B) 1000 and 2500 ng/mL of DCIT, CIT and PB, and NTRIP and AMI, 
respectively  
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3.6 SPE Method Validation 
The precision of the method was measured as the percent coefficient of variation of RR with 6-
point standard curves, where replicates (n = 8) were made of spiked BTE. With the exception of 
PB, which reached 31.9 %, all % CV of interday replicates were below 30 %, varying from 0.2 
to 22.8 % for DCIT, 8.3 to 15.1 % for CIT, 1.9 to 11.9 % for NTRIP, 0.2 to 15.5 % for AMI and 
5.0 to 31.9 % for PB. Replicates with a % CV higher than 20 % were observed at concentrations 
lower than 25 ng/mL. For the intraday replicates, a maximum % CV of 12.7, 9.8, 8.8, 26.8 and 
8.6 % was calculated for DCIT, CIT, NTRIP, AMI and PB, respectively. A standard curve was 
run with each analysis to measure the % CV. These curves confirmed the variability did not 
exceed the validation criterion of 20 % and that the cut off level was no different from the 
previous value obtained. Linearity of RR was observed between 5 and 2000 ng/mL for DCIT, 
CIT and PB 5 and 5000 ng/mL for NTRIP and AMI. R² values were no lower than 0.996, 0.996, 
0.980, 0.997 and 0.997 for DCIT, CIT, NTRIP, AMI and PB, respectively. Figures 12 and 13 
demonstrate standard curves for PB, DCIT and CIT, and NTRIP and AMI, respectively. 
The cut off level and LOQ were determined with replicates (n = 9) of 5, 10 and 25 ng/mL made 
from drug free BTE. The cut off level for all analytes was 5 ng/mL, while the LOQ was 10 
ng/mL for DCIT, CIT and PB, and 25 ng/mL for NTRIP and AMI.  
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Figure 12: Average response ratio of PB, DCIT and CIT in function of concentration 
 
 
Figure 13: Average response ration of NTRIP and AMI in function of concentration 
 
 
3.7 Stability 
It is important to study the stability of drugs and metabolites under all extraction conditions. 
Extraction methods such as MAE and USE are relatively new to forensic toxicology laboratories 
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and have not been studied as intensively as the passive incubation technique. Furthermore, 
compared to the standard conditions of passive extraction, microwave irradiation reaches high 
temperatures more quickly and ultrasonic agitation creates cavities of extremely high pressure 
and temperature. These aggressive conditions could lead to analyte degradation by hydrolytic 
losses, limiting their use in practice.  
 Drug stability at two different concentrations, low-mid and mid-high, were examined in MeOH 
and EA for passive, microwave and ultrasonic extraction. Control bone (2 g) was spiked with 
200 or 2000 ng/mL of DCIT, CIT and PB, and 500 or 5000 ng/mL of NTRIP and AMI, and 
solvent volume was brought up to 10 mL. The stability of each drug was determined by 
comparing analyte RR after being exposed to a certain extraction method for a pre-determined 
time periods. ANOVA (one way) with post-hoc analysis, along with the validation criterion of ± 
20 % mean variability, were used to determine if the variation in RR values between different 
extraction times was significantly greater than that observed between replicates at each 
extraction time. In general, no significant effect was observed from time of exposure on assay 
response for all three extraction methods.  
 
3.7.1 Standard Passive Extraction Stability 
Overall the stability study showed no significant loss of any analyte throughout 96 h of passive 
solvent extraction. Figure 14 shows an example of the average response ratio of (A) 200 ng/mL 
and (B) 2000 ng/mL of pentobarbital in function of standard passive extraction time in MEOH 
and EA.  
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Figure 14: Stability of PB, (A) 200 ng/mL and (B) 2000 ng/mL, in MeOH and EA through 
96 h of passive extraction 
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3.7.2 Microwave-Assisted Extraction Stability 
The drugs were stable through 30 min of microwave irradiation, and no significant analyte loss 
was noticed. A trend at 30 min of irradiation was observed, where the average RR increased, 
most likely due to solvent evaporation. An example is illustrated in figure 15. 
 
 
 
Figure 15: Stability of CIT, (A) 200 ng/mL and (B) 2000 ng/mL, in MeOH and EA through 
30 min of microwave irradiation  
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3.7.3 Ultrasound Solvent Extraction Stability 
A slight decrease in average RR was observed throughout ultrasonication time as illustrated in 
figure 16. No significant difference was observed, with the exception of NTRIP at 500 ng/mL in 
EA.   
A decrease in RR reported does not necessarily mean a loss of the analyte due to instability. 
Other factors contribute to observing a decrease in levels, including the possibility of drugs being 
adsorbed onto the glass or bone and the increase in background material extracted with time. In 
addition, as the ultrasonication continues over time, the amount of interfering components 
desorbed from bone, along with the analytes, accumulate into the solvent, possibly increasing the 
baseline and appearing as a decrease in analyte level. No clear trend was observed, given that the 
losses are not consistent at both concentrations and in both solvents. Therefore, the nature in 
changes in assay response of this extraction method was undetermined. It is therefore not clear if 
the loss of analytical signal represents drug degradation or suggests another process such as 
adsorptive loss.  
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Figure 16: Stability of AMI, (A) 500 ng/mL and (B) 5000 ng/mL, in MeOH and EA through 
90 min of ultrasonic agitation  
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3.8 Optimization/Characterization of Drug Extraction from Bone 
Optimization of the extraction methods was carried out by sequential extractions of skeletal 
tissue in aliquots of fresh solvent. After certain predetermined periods of time, the solvent was 
recovered and replaced with a fresh solvent. Each solvent fraction recovered was analyzed 
separately.  
 
3.8.1 Effect of Extracting Solvent 
In general, samples extracted in MeOH tended to have a significantly greater yield compared to 
those extracted in EA. This trend was observed in all three extraction methods, with one 
exception.  
 
3.8.1.1 Standard Passive Extraction 
Statistical analysis showed a significant difference (p < 0.05) between analyte recovery in long 
term passive incubation samples in MeOH and those incubated in EA for PB and NTRIP for both 
masses, and DCIT, CIT and AMI for 2 g samples only (figure 17 A). 
As for short term interval passive incubation, a significant difference was observed for CIT, 
NTRIP, AMI and PB for both masses, and DCIT for 2 g samples (figure 17 B).  
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3.8.1.2 MAE 
All samples submitted to microwave irradiation showed significant differences when comparing 
extraction yields of samples extracted in MeOH and those extracted in EA in both masses for all 
analytes (figure 17 C).  
 
3.8.1.3 USE 
A statistical difference in extraction yield was observed for the majority of the samples which 
underwent ultrasonication, where samples extracted in MeOH resulted in higher analyte recovery 
compared to sample extracted in EA, with one exception.  DCIT was not detected in all samples 
subjected to USE in EA, and was only slightly above the detection limit in the first round of 
samples extracted in MeOH (figure 17 D). Surprisingly, CIT levels were significantly higher 
when extracted in EA compared to those extracted in MeOH for the 1 g samples. This was the 
only occurrence where EA surpassed MeOH as extracting solvent. Levels were significantly 
higher in MeOH in both masses for NTRIP and AMI, and at the 2 g samples for PB.  
 
3.8.2 Effect of Sample Mass  
The effect of sample mass did not appear to influence the mass-normalized extraction yield, and 
no common trend was observed in all extraction methods or extraction solvents, with one 
exception (figure 17). Pentobarbital levels were significantly higher in the 1 g samples compared 
to the 2 g samples submitted to microwave irradiation in methanol. No significant differences 
were observed with any other analyte when comparing different mass in both solvents and in all 
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three extraction methods, suggesting that the increase in sample mass resulted in proportional 
absolute analyte yield. Therefore, the masses sampled were not too large for the solvent volume.  
 
3.8.3 Effect of Extracting Solvent and Sample Mass on Extraction Time 
3.8.3.1 Standard Passive Extraction 
The effect of extraction solvent and sample mass on the extraction rate was also examined. It 
appears the majority of the analytes were extracted within 24 and 48-72 h of standard passive 
extraction in MeOH and EA, respectively. Exceptions were observed where levels of NTRIP and 
AMI from the 2 g samples extracted in EA were still near the cut off level even after 96 h of 
passive incubation. On the other hand, the sample mass did not seem to have any effect on the 
extraction rate for samples incubated passively. Figure 18 demonstrates an example of levels of 
AMI recovered from long interval passive solvent extraction of 1 and 2 g of porcine bone in 10 
mL of (A) EA and (B) MeOH. 
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Figure 17: Average (n = 3) of the sum of RR/m of sequential extraction aliquots of DCIT, 
CIT, NTRIP, AMI and PB from 1 and 2 g samples extracted in MeOH and EA (A) Long 
and (B) short term standard passive extraction, (C) MAE and (D) USE  
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Figure 18: Average RR/m of AMI from 1 and 2 g bone samples submitted to long term 
interval standard passive extraction in 10 mL of (A) EA and (B) MeOH, in function of 
passive incubation time 
 
Upon review of the evaluation of the long term intervals of passive incubation, results 
demonstrated maximum yield within the first 24 h in MeOH. For this reason, a second set of 
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the incremental recovery with short term sampling. Shorter intervals of passive incubation were 
not initially considered since extraction times reported in the literature have not been shorter than 
12 h, with one exception. Desrosiers et al. have examined samples submitted to passive 
extraction for periods of time including 1, 6 and 12 hours, where the majority of the analytes had 
reached maximum yield within 6 h [14]. The results seemed to be drug dependent.  
Results from the short intervals of passive incubation indicate that maximum recovery of DCIT, 
CIT, NTRIP, AMI and PB was achieved within 6, 21, 15, 10 and 30 min, respectively, in both 
extracting solvents. In this short time, no major difference was observed when comparing the 
extraction time of samples extracted in MeOH and those extracted in EA. It is important to note 
that no report was found in the literature regarding short term passive incubation with fresh bone. 
As noted before, porosity of bone increases with time, thus fresh bone may behave differently. 
Levels of nortriptyline from short intervals of passive solvent extraction are illustrated in figure 
19. No trends were observed on the extraction rate with respect to the sample mass. 
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Figure 19: Average RR/m of NTRIP from 1 and 2 g bone samples submitted to short term 
interval standard passive extraction in 10 mL of (A) EA and (B) MeOH, in function of 
passive incubation time 
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all other analytes levels were near the cut off level up to 9 and 15 min for samples extracted in 
MeOH and EA, respectively. The average mass-normalized response ratio of NTRIP of 1 and 2 g 
bone samples submitted to microwave irradiation is illustrated in figure 20. 
 
 
 
Figure 20: Average response (RR/m) of NTRIP from 1 and 2 g bone samples submitted to 
MAE in 10 mL of (A) EA and (B) MeOH, in function of irradiation time. 
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3.8.3.3 USE 
The majority of the analytes recovered from samples extracted in MeOH achieved maximum 
yield within 30-45 min of ultrasonic agitation, while it took 45-60 min for samples extracted in 
EA. Some exceptions occurred, where even after 90 min of ultrasonic agitation in EA levels of 
CIT and AMI for 1 g and both masses, respectively, were still above the cut off level. Similar 
results were observed with standard passive extraction. The average mass-normalized response 
ratio of CIT of 1 and 2 g bone samples submitted to ultrasonic agitation in (A) EA and (B) 
MeOH is illustrated in figure 21. 
 
3.8.4 Effect of Solvent Volume 
Based on the assessment of the influence of extraction solvent, sample mass and extraction time, 
the influence of the solvent volume on the extraction yield was investigated in a second set of 
extractions. Since MeOH resulted in greater rate and recovery, it was chosen over EA for all 
further extractions. Also, since the sample mass did not have any effect on the recovery and due 
to the limited amount of bone, all samples were prepared with 1 g of ground bone. Thus samples 
(n = 3) containing 1 g of bone were extracted in 5, 10 or 15 mL of MeOH. Furthermore, the 
extraction times were cut down to 72 h, 15 min and 45 min for passive, MAE and USE, 
respectively.  
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Figure 21: Average RR/m of CIT from 1 and 2 g bone samples submitted to USE in 10 mL 
of (A) EA and (B) MeOH, in function of ultrasonic agitation time. 
 
 
 
0	  
0.1	  
0.2	  
0.3	  
0.4	  
0.5	  
0.6	  
0.7	  
0	   15	   30	   45	   60	   75	   90	  
Av
er
ag
e	  
RR
/m
	  
Extrac6on	  6me	  (min)	  
EA	  1g	  
EA	  2g	  
LOD	  
0	  
0.1	  
0.2	  
0.3	  
0.4	  
0.5	  
0.6	  
0	   15	   30	   45	   60	   75	   90	  
Av
er
ag
e	  
RR
/m
	  
Extrac6on	  6me	  (min)	  
MeOH	  1g	  
MeOH	  2g	  
LOD	  
B 
A 
83	  
	  
No significant differences were observed for all analytes passively incubated in different MeOH 
volumes, with the exception of PB. The 15 mL samples yield three times the level of drugs 
extracted in the 5 and 10 mL samples (figure 22 A). For samples irradiated by microwaves, 
similarly to the passive incubation samples, ANOVA one-way results show no significant 
difference in all analytes (figure 22 B). Finally, for samples submitted to USE, most analytes 
showed no significant difference, but lower solvent volumes (5 and 10 mL) resulted in 
significantly higher extraction yields than 15 mL samples for DCIT and CIT. 
 
3.8.5 Effect of Microwave Power 
The influence of microwave power on the extraction yield was investigated using samples (n = 
3) containing 1 g of porcine bone in 5 mL of MeOH. Samples were irradiated for a total of 15 
min at a power of 100, 80, 50 or 20 %, which are equivalent to 1100, 880, 550 and 220 W, 
respectively. With the exception of AMI and NTRIP, no significant difference was observed 
when comparing analyte yields from samples irradiated at different powers. A significantly 
higher yield resulted from samples extracted at 100 % than those extracted at 80, 50 and 20 % 
for AMI and NTRIP (figure 23). 
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Figure 22: Average (n = 3) of the sum of RR/m of sequential extraction aliquots of DCIT, 
CIT, NTRIP, AMI and PB from 1 g bone samples extracted in 5, 10 and 15 mL of MeOH 
by (A) standard passive extraction, (B) MAE and (C) USE 
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Figure 23: Average (n = 3) of the sum of RR/m of sequential extraction aliquots of DCIT, 
CIT, NTRIP, AMI and PB from 1 g bone samples submitted to MAE at 100, 80, 50 and 20 
% power in 5 mL of methanol 
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in 5 mL of MeOH were used and vacuum degassing of water (Dg H2O) and methanol (Dg 
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other analytes did not show any significant difference in yields when comparing the different 
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Figure 24: Average (n = 3) of the sum of RR/m of sequential extraction aliquots of DCIT, 
CIT, NTRIP, AMI and PB from 1 g bone samples submitted to USE in 5 mL of MeOH with 
degassed bath water and extraction solvent 
 
When comparing the recovery levels of the three extraction methods, higher yields were obtained 
in general when samples were being irradiated by microwaves compared to passively incubated 
or submitted to ultrasonic waves (figure 22).  
 
 
3.9  PB Analysis by GC-MS 
Pentobarbital in porcine bone was analyzed by GC-MS and had a retention time of 
approximately 6.80 min (figure 25). Chromatograms of negative controls show minimum 
background noise at these retention times, causing little to no interference with the analyte and 
ISTD signals. Pentobarbital and secobarbital were identified with a combination of retention 
time and peak ratios of quantitative to qualitative ions (figure 26 (A) PB and (B) SB). 
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Figure 25: Total ion chromatogram (TIC) of 1000 ng of PB (6.82 min) and SB (7.08 min) 
standards 
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Figure 26: Mass spectra (SIM mode) of (A) PB and (B) SB 
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3.10  DCIT, CIT, NTRIP and AMI Analysis by UPLC-DAD 
On the other hand, AMI, CIT and selected metabolites were analyzed by UPLC-DAD. Figure 27 
shows a chromatogram containing the UV absorbance all four analytes (100 ng/mL) and the 
ISTD (250 ng/mL) at 240 nm, with retention times of approximately 2.04, 2.22, 3.97, 4.37 and 
3.33 min for DCIT, CIT, NTRIP, AMI and DMI, respectively. Chromatograms of negative 
controls show minimum background at these retention times (figure 28). Analytes were 
identified by a combination of retention time (± 3 standard deviation in relation to standard 
samples) and their specific UV absorbance spectrum. Spectra of parent drug and metabolite can 
be very similar (figure 29), it is therefore very important to pay attention to the retention time 
when identifying peaks.  
 
Figure 27: UPLC-DAD chromatogram of BTE spiked with 100 ng/mL of DCIT (2.04 min), 
CIT (2.22 min), NTRIP (3.97 min), AMI (4.37 min) and 250 ng of the internal standard 
DMI (3.33 min) at 240 nm 
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Figure 28: UPLC-DAD chromatogram of 1 g sample of control pig bone after 45 min of 
ultrasonic agitation (A) at 290 nm, (B) at 240 nm and (C) ranging from 210-400 nm 
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Wavelength (nm) 
Figure 29: UV absorbance spectra of (A) CIT and (B) DCIT 
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Wavelength (nm) 
 
Figure 30: UV absorbance spectra of (A) AMI and (B) NTRIP 
 
As seen in figure 31 B and C, an interference peak was eluted along with DMI in the positive pig 
samples. Obtaining the spectrum at 240 nm did not help (figure 31 B) since the spectrum of the 
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unknown compound also shows a strong absorbance at this wave length (figure 32 B). In order to 
overcome the interference, a different wave length was chosen for DMI; 290 nm (figure 32 A). 
When overlaying the two spectra, it is clear the interference is minimized when using 290 nm 
wavelength (figure 32 C). 
 
 
 
Figure 31:  UPLC-DAD chromatogram of 2 g sample of pig bone after 3 min of microwave 
irradiation (A) at 290 nm, (B) at 240 nm) and (C) ranging from 210-400 nm 
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Wavelength (nm) 
Figure 32: UV absorbance spectra of (A) DMI, (B) unknown compound and (C) overlay of 
both compounds 
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Chapter 4 
4 Conclusion 
4.1 Implication of the Research 
The results show that methanol was a better extraction solvent for all three isolation methods 
(figure 17 A-D) and mass did not have an effect on the mass-normalized analyte yield. Certain 
analyte (DCIT and CIT) recovery levels were higher when extracted with less extraction solvent 
for USE, while more solvent was necessary for passive incubation, making USE a more cost 
effective and environmentally friendly technique (figure 22). Full microwave power resulted in 
higher recovery levels of some analytes (NTRIP and AMI) (figure 23), while samples subjected 
to Dg H2O + Dg MeOH, resulted in higher yields on one occasion (AMI) (figure 24). When 
comparing maximum yield, a general trend indicated that MAE obtained higher analyte recovery 
compared to passive extraction and USE (figure 22).  
Finally, a total of 30, 15 and 45 min were required to achieve maximum recovery by standard 
passive extraction, microwave irradiation and ultrasound agitation, respectively (figure 18-21), 
therefore making standard passive extraction and MAE more time effective. It is clearly 
demonstrated by these results that the extraction time required to isolate analytes of forensic 
toxicological interest by passive incubation from skeletal tissue is much shorter than what has 
been reported in the literature thus far. 
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4.2 Future Work 
 
Drug analysis in skeletal tissue is still relatively new to forensic toxicology; therefore much more 
research is required. The comparison of samples submitted to standard passive extraction with 
manual vortexing and without vortexing should be considered to observe the influence of sample 
mixing in respect to analyte yield. The use of smaller sample mass (ex: 0.5 g) is also worth 
investigating.  
It would be interesting to compare the analyte yield from samples irradiated in a domestic 
microwave to those submitted to laboratory-grade MAE. Also, the comparison of analyte 
recovery from closed- and open-vessel systems would be important to note.  
In addition, it would also be interesting to examine the difference in analyte recovery from 
samples extracted by ultrasound agitation using different frequencies. Finally, the comparison of 
analyte extraction yield and rate from a water bath to a probe should also be investigated.  
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